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CHAPTER 1 
INTRODUCTION 
Herbal drug constitute a major part in all the traditional system of medicine.  
Herbal medicine is a triumph of popular therapeutic diversity.  Plants have been used 
for medicine since time immemorial because they have fitted immediate personal 
need and are easily accessible and inexpensive.
1 
The Indian sub continent is enriched by a variety of flora both aromatic and 
medicinal plants. This is due to the wide diversity of agro-climatic conditions ranging 
from deserts to swamplants.  India is virtually considered as the herbarium of the 
world and has been called the “BOTANICAL GARDEN OF THE WORLD”. This 
botanical wealth constitute more than 2200 species of medicinal and essential oil 
containing plants.
3 
HERBAL PHARMACOVIGILANCE
1
 
Pharmacovigilance is the science and activities relating to the detection, 
assessment, understanding and prevention of adverse effect or any other possible drug 
related problems. Herbal pharmacovigilance is the need of the day.  Though in India 
we have so many ancient systems of medicine like Ayurveda, Siddha, Unani etc, 
which are being practiced from time immemorial it’s a pity that proper 
pharmacovigilance is lacking.  There is no proper evidence been started in many 
countries.  By analog with conventional pharmacovigilance, herbal 
pharmacovigilance aims at the detection of serious adverse reactions, at the 
quantification of their incidence, and at the identification of contributive and 
modifying factors. 
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Proper pharmacovigilance of all the phyto-therapeutic claims on the herbals is 
essential for the treatment and evaluation of the herbal health care around the globe. 
Thus, herbal pharmacovigilance is not a negative tool but a neutral one, especially 
when it identifies a new serious herbal health risk.  Pharmacovigilance can also be 
reassuring, however, by providing evidence that certain herbal health risks are absent 
or negligibly small.  Thus, it can help booster one of the main features of 
phytotherapeuticals, namely their relative safety when compared to conventional 
pharmaceutics. 
 
The use of plants for medicines around the world still vastly exceeds the use of 
modern synthetic drugs.  Such activity is not completely dismissed in scientific 
society and plants are also appreciated in pharmaceutical research as the major 
resource for new medicines and a growing body of medical literature supports the 
clinical efficacy of herbal treatments.  Even where traditional use has largely died out 
in developed countries, there is an increasing yearning for a new deal in healthcare in 
which the old remedies feature strongly. 
 
Natural products will continue to be important in three areas of drug discovery 
 As targets for production by biotechnology 
 As a source of new lead compounds of novel chemical structure and 
 As the active ingredients of useful treatments derived from traditional systems 
of medicine. 
The recent analysis confirmed that among the top 20 brands of drugs for the 
treatment of various ailments about 40% are natural products and derived natural 
products.  This survey reveals the important of herbs in drug discovery.
 2
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ANTIOXIDANTS 
48,76
 
Oxygen is essential for the survival of all living thing in the earth.  Oxygen is 
being utilized in many physiological and metabolic processes of which about 5% gets 
reduced to free radicals.  Free radicals are species with one or more unpaired electrons 
which reacts with electron acceptors such as molecular Oxygen to form reactive 
oxygen species (ROS).  The various ROS are superoxide anion radicals (O2 ).  
Hydrogen peroxide, hydroxyl radical and singlet O2 .  The short lived ROS reacts with 
non radicals and produce chain reactions. 
  
Antioxidants are substances which delays oxidation process, inhibit the 
polymerization chain reaction, counter act the oxidative damage due to ROS and 
thereby improve the quality of life.  They may provide protection against chronic 
diseases such as cancer, neurodegenerative diseases, inflammatory and cardiovascular 
diseases.  
 
The antioxidant enzymes includes superoxide dismutase (SOD), peroxidase 
(P-ase), catalase (C-ase) and some natural antioxidants include GSH reduced 
Glutathione and phenolic compounds (tocopherol, flavonoid, phenolic acids). 
Many plants contain substantial amount of antioxidants including vitamin C, 
vitamin E, carotenoids, flavanoids, tannins etc ., and thus can be utilizsed to scavenge 
the excess free radicals from human body.  
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HEART FAILURE 
4,5,6,7
 
Heart failure is a clinical syndrome that occur in patients who because of an 
inherited or acquired abnormality of cardiac structure and or function, develop a 
constellation of clinical symptoms (dysnea and fatigue) and signs (edema and rates) 
that lead to frequent hospitilalization a poor quality of life and a shortened life 
expectancy. 
ETIOLOGY 
I) Depressed ejection fraction (<40%) 
A) Coronary artery disease – myocardial infarction, myocardial ischemia. 
B) Chronic pressure overload- hypertension, obstructive valvular disease 
C) Chronic volume overload- regurgitant valvular disease, intracardiac 
shunting, extracardiac shunting. 
D) Nonischemic dilated cardiomyopathy- familial genetic disorder, infiltrative 
disorders, toxic/drug induced damage, metabolic disorder, viral, chronic 
disease. 
E) Disorder of rate and rhythm-chronic bradyarrhythmia, chronic 
tachyarrhythmia.  
II) Preserved ejection fraction (>40-50%) 
A) Pathological hypertrophy - Primary (hypertrophic 
cardiomyopathies);Secondary (hypertension) 
B) Restrictive cardiomyopathy - Infiltrative disorders (amyloidosis, 
sarcoidosis) ;Storage disease (hemochromatosis); Fibrosis -
Endomyocardial disease 
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III) Pulmonary heart disease 
Pulmonary vascular disorders 
IV) High-output states 
Metabolic disorders, Thyrotoxicosis, Nutritional disorders (beriberi), 
Excessive blood flow requirement, Systemic arterioxenous shunting, 
Chronic anemia 
 
DIAGNOSIS 
1. Routine laboratory testing 
2. Electrocardiogram 
3. Chest X-ray 
4. Assessment of LV function 
5. Biomarkers 
6. Excercise testing 
 
PHARMACOLOGICAL MANAGEMENT 
CHRONIC HEART FAILURE 
1. Diuretics 
2. Angiotensin converting enzyme inhibitors 
3. Angiotensin receptor blockers 
4. β-receptor blockers 
5. Anticoagulant and antiplatelet therapy 
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ACUTE HEART FAILURE 
1. Vasodilators 
2. Ionotropic agents 
3. Vasoconstriction 
 
CARDIOMYOPATHY 
Cardiomyopathy are a group of diseases that primarily affect the heart muscles 
and are unable to pump the blood throughout the body. 
 
CLINICAL CLASSIFICATION OF CARDIOMYOTHIES 
1. Dilated cardiomyopathy 
Left or right ventricular enlargement, impaired systolic function, congestive 
heart failure, arrhythmias, embolic. 
2. Restrictive cardiomyopathy 
Endomyocardial scarring or myocardial infiltration resulting in restriction of 
left and or right ventricular filling. 
3. Hypertrophic cardiomyopathy 
Disproportionate left ventriculat hypertrophy, typically involving septum more 
then free wall, with or without an intraventricular systolic pressure gradient, 
usually of a non dilated left ventricular cavity. 
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CARDIOTOXICITY 
Cardiotoxicity is a condition where the damage of heart muscles occur and the 
heart may not be able to pump the blood throughout the body.  Severe cardiotoxicity 
leads to cardiomyopathy. 
CARDIOTOXIC AGENT 
A variety of pharmacologic agents may damage the myocardium acutely, 
producing a pattern of inflammation (myocarditis) or may even lead to chronic 
damage as seen in DCM.  Certain drugs may produce ECG abnormalities alone while 
others may precipitate CHF and death.  Some of the cardiotoxic agents include 
doxorubicin, daunorubicin, cyclophosphamide, phenothiazine, chloroquine, cocaine, 
trastuzumab etc. 
 
Doxorubicin, an anthracyclic derivative is a powerful antineoplastic agent but 
severe cardiomyopathy and heart failure have been observed in doxorubicin treated 
cancer patients hence its use being limited. It causes lipid peroxidation of the 
myofibre membranes resulting in myofibre swelling, vacuolization, fatty changes, 
cytolysis systolic dysfunction and ventricular tachyarrthymic occurs in a dose 
dependent manner. 
CARDIOPROTECTIVE HERBS 
Digitalis purpurea 
Strophanthus kombe 
Gymnema sylvestre 
Terminalia arjuna 
Euodia officinalis  
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RHEUMATOID ARTHRITIS 
8,9,10
 
Rheumatoid arthritis is traditionally, a chronic inflammatory autoimmune 
disorder (where the body own immune system attacks itself deliberately).  It is a 
systemic disorder and the systemic manifestations include homological, pulmonary, 
neurological and cardiovascular abnormalities. The joints most commonly affected 
were neck, shoulder, elbows, hip, knees and ankles. 
 
EPIDEMIOLOGY 
Rheumatoid arthritis affects almost 1% of the adults of the developed 
population in the world.  Ten years after the onset of the disease, 60% of the patients 
showed significant disability and after 20 years mark, more than half of the patients 
showed severe disability or even dead.  The highest mortality in rheumatoid arthritis 
population is directly attributed to excess cardiovascular disease.  These patients 
suffer more myocardial infarction, cerebrovascular accidents and even heart failure 
than those without rheumatoid arthritis. 
 
ETIOLOGY 
 Etiology is not clearly known 
 It occurs in immunogenetically predisposed individuals to the effect of 
microbial agents acting as trigger antigens. 
 Due to the existence of infectious agents lack as mycoplasma, Epstein barr 
virus (EBR) cytomegalovirus (CMV) or rubella. 
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SIGNS AND SYMPTOMS 
 Pain and swelling of joints in symmetrical fashion. 
 Onset of disease begins with fatigue, weakness, morning stiffness, arthralgia, 
mylagia, redness and difficult movement. 
 Rheumatoid nodules also seen close to the joints of neck, shoulder, elbow, hip, 
knees and ankles. 
 
DIAGNOSIS 
 Clinicans usually depend on the presence or absence of rheumatoid factor 
(RF) in the blood.  But this diagnosis is not always correct. 
 In advanced cases radiological abnormalities such as narrowing of joint space 
and ulnar, deviation of fingers and radial deviation of wrist are seen in x-ray 
diagnosis. 
 Laboratory findings include mild normocytic, normochromic anemia, elevated 
ESR, mild leucocytosis and hypergamma globulinarmia. 
 Anticyclic citrullinated peptide (CCP) antibody test is a recent serological 
diagnostic tool. 
 
TREATMENT 
 NSAIDS were used first to afford symptomatic relief from pain, swelling, 
morning stiffness, immobility, but do not arrest the disease. 
 Disease modified anti arthyritic drugs includes – gold, d-pencillamine, 
chloroquine, sulfasalazine, leflunomine, immunosuppresants.  These are given 
NSAIDS have failed or when deformity and bony changes progressive rapidly. 
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HERBAL REMEDIES 
 Ficus benghlensis. 
 Capsicum annum 
 Menthe arvensis  
 Alpinia officinarum 
 Aconitum napellus 
 Trachyspermum roxburghianum 
 
RHEUMATIC FEVER 
7,8,11
 
Rheumatic fever is a systemic, post-streptococcal non-suppurative 
inflammatory disease, principally affecting the heart, joints, central nervous system, 
skin and subcutaneous tissues.The chronic stage of rheumatic fever involves all the 
layers of the heart (pancarditis) leading to rheumatic heart diseases (RHD). 
EPIDERMIOLOGY 
This disease appears most common in childrens between 5 to 15 years of age 
when the streptococcal infection is more frequent and intense.  The incidence of 
disease has declined in the developed countries but still prevails in developing 
countries like India, Pakistan, parts of Africa and South America.  About 75% of 
rheumatoid fever patients have arthritis and 2/3 of patients have carditis. 
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ETIOLOGY 
Certain strains of beta haemolytic streptococcal cause pharyngitis and provoke 
the necessary antibodies for the causation of rheumatic fever. 
 
STREPTOCOCCUS DISEASES  
STREPTOCOCCUS PYROGENS 
1. Pyrogenic infection 
 Respiratory tract  - acute tonsillitis or pharyngitis (sore throat), scarlet fever                     
 Skin infection - infection of wound, burns etc. 
 Deep infection - bone and joint infection, septicaemia, abscess in internal 
organs. 
2. Non-suppurative complications 
Rheumatic fever, acute glomerulonephritis. 
ENTEROCOCCUS FAECALIS 
Endocarditis. 
STREPTOCOCCI VIRIDANS 
Endocarditis and dental caries. 
MECHANISMS 
Throat infection due to β-haemolytic streptococcus (Group A) – immune 
response – cell mediated and antibodies to streptococcal antigens – cross reaction with 
cardiac and connective tissues of susceptible individual. 
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Throat infection due to β-haemolytic streptococcus 
 
Immune reponse 
 
 
 
 
 
 
    
 
When the immune system begins to attack the heart, it may attack any of the 3 
layers (pancarditis) of the pericardium, myocardium and endocardium. The causative 
organism not only causes the cardiac manifestations it also leads to extra-cardiac 
manifestations like polyarthritis, subcutaneous, nodules, erythema marginatum, 
rheumatic arthritis etc. 
TREATMENT 
Rheumatic fever can be stopped to be transformed to rheumatic heart diseases by 
using antibiotics against Streptococcus pyrogens.  Penicillin is the drug of choice. 
Cell mediated and ANTIBODIES 
to STREPTOCOCCAL ANTIGENS 
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CHAPTER 2 
LITERATURE SURVEY 
ETHNOMEDICAL INFORMATION 
13, 14, 15
 
1. In Ayurveda, it was stated that the plant possess anthelmintic, antipyretic, 
alexitaric, tonic, digestive activity and improves appetite, memory, voice and 
complexion. It was also used to cure leucoderma, poisonous bites of insects, 
epilepsy, salivation and fever. 
2. The Native American tribes used this plant to relieve constipation, diarrhoea 
and vomiting
.
 
3. The Chinese used this plant for headache, ulcer, sinus problems. 
4. The plant was considered to be useful in the treatment of long standing case of 
malaria. 
5. An infusion of the plant has been used to treat rheumatism, kidney diseases 
and tuberculosis.  
6. The fruit has been used as antibacterial, antifungal, antimalarial, 
antispasmodic, antitussive, cytoxic, hypoglycaemic and stomachic 
7. Historically the roots were being used in the treatment of scrofulous tumours, 
ulcers, boils and abscesses. 
8. The juice of leaves and fruits were believed to be  used for small pox and roots 
are used for cancer . 
9. Decoction of the seeds were used for the treatment of bladder complaints. 
10. The plant is considered as medicinal plant of West Bengal and wild edible 
plant of Meghalaya. 
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LEAVES 
PHYTOCHEMISTRY 
1. Boyer, Gregory L et.al (1986) isolated and identified 7′- hydroxy(-)-R-abscisic 
acid by mass spectroscopy and optical rotation dispersion as a metabolite of 
feeding (-)-R abscisic acid to X. strumarium.
 16
 
2. Bisht NPS et. al (1979) isolated strumasterol, oleic acid, 3,4 – dihydroxy 
cinnamic acid, β sitosterol- D-glucoside  from the leaves of X. strumarium. 17 
3. Ahn. J. W. et.al (1996) isolated the cytotoxic compound (xanthatin, 8-epi-
xantatine, 8-epi-tomentosin) from the leaves of X. Strumarium.
 18
 
     PHARMACOLOGY 
1. Reddy UM et.al (1981) studied the antifungal activity against (Drechslera 
rostrata, Curvularia lunata and Furaruim oxysporum) and antibacterial 
activity  aganist (E.coli, Proteus vulgaris, Klebsiella species, Pseudomonas 
fluoresecens, sarcina lutea and Bacillus megaterium) leaf extract of  X. 
strumarium.
 19
 
2. Misra SB et.al (1982) studied the antifungal activity against Ustilago tritici, U. 
Hordei.
 20
 
3. Kishore N et.al (1983) showed that ethanolic extract of X. strumarium 
completely inhibited the mycelial growth of F. Momiliforme 
21
. 
4. Nandal SN et.al (1984) screened X. strumarium for nemeticidal activity 
against Meloidogyne javanica.
 22
 
5. Renu et. el (1984) studied the fungal toxicity of leaf extract of X. strumarium 
against Rhizoctonia soloni kushm.
 23
 
Literature survey 
 
Department of Pharmacognosy, MMC.  15 
 
6. Dongre TK et.al (1986) studied that leaf extract of X. strumarium decreases 
the egg laying of Eariasvitella F.
 24
 
7. Akarte A.S. et.al (2010) evaluated the antinociceptive effect of leaf extract of 
X. strumarium.
 25
 
8. Kim YS et.al (2003) isolated two xanthanolide sesquiterpene lactones (8-epi-
xanthatin and 8-epi-xanthatin epoxide) from the leaves of X. strumarium and 
demonstrated the inhibition of the proliferation of cultured human tumour 
cells. 
26
 
9. Talakal et.al (1995) screened for both invitro and invivo antitrypanosomal 
activity of leaf extract of X. Strumarium
27
 
10. Torres, J. Molina et.al (1991) studied the diurnal changes in the incorporation 
of (U-14 C) tyrosine into tocopherols and plastoquinone in leaves of X. 
Strumarium. .
 29
 
11. Scherer et.al (2009) studied the antioxidant activity on the methanolic extract 
by DPPH and nitric oxide scavenging methods.
 
.
 30
 
PHARMACOGNOSY 
1. Keese RJ et.al (2006) studied the effect of monosodium methanarsonate on 
cuticle wax content of X. strumarium.
 31
 
FRUITS 
PHYTOCHEMISTRY: 
1. Ma Y.T. et.al (1999) isolated new thiazinedione (7-hydroxymethyl-8,8-
dimethyl 1-4, 8-dihydrobenzo {1-4} thiazine-3,5- dione)  and phenolic 
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compounds (caffeic acid, potassium 3-O-caffeoyl quinate, 1,5- di-O-caffeoyl 
quinic acid; 1,3,5- tri –O- caffeoyl quinic acid. 32 
2. Quin .L. et.al (2007) isolated new thiazinedione,  xanthiazone, chlorogenic 
acid, ferulic acid, formononetin and ononin from the fruits of X. strumarium.
 33
 
3. Agata Isao et.al (1993) isolated 1,3,5-tri-O-caffeoylquinic acid and 3,5-di-O-
caffeoylquinic acid from the fruits of X. strumarium. .
 34
 
 PHARMACOLOGY 
1. Lee B.H et.al (2009) isolated 3,4-dihydroxy benzaldehyde and studied the 
apoptotic cell death through inhibition of protein kinase CK II activity on 
fruits of X. strumarium. .
 35
 
2. Hsu FL et.al (2000) isolated the active principle, caffeic acid and studied the 
antihyperglycemic effect on the fruits of X. strumarium. .
 36
 
3. Hong SH et.al (2003) studied the inhibitory effect on mass cell mediated 
allergy reactions on fruits of X. strumarium. .
 37
 
PHARMACOGNOSY 
1. Hamada T et.al (1989) reported the pharmacognostical studies on fruits of X. 
Strumarium .
 38
 
SEEDS 
PHYTOCHEMISTRY 
1. Cole RJ et.al (1981) isolated and redefined the toxic agent 
(carboxyatractyloside) from the seeds  of X. strumarium. .
 39
 
2. UI’ Chenko, N.T. et. al (2001) analysed neutral lipids,ordinary and 
hydroxylated fatty acids from the seeds of X. strumarium. .
 40
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PHARMACOLOGY 
1. Lee C.L. et. al (2009) isolated xanthialdehyde and (-)- xanthienopyran 
inhibitors of superoxide anion generation by activated neutrophils from the 
seeds of X. strumarium. .
 41
 
2. Bark KM et.al (2010) evaluated the phytotoxic potential of seed oil of X. 
strumarium. .
 42
 
AERIAL PART 
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1. Bohlmann F. et.al (1982) isolated 2-epi-xanthumin and 8-epi-xanthatin-1β, 5β-
epoxide from the aerial part of Xanthium indicum. .
 43
 
2. Ahmed A.A. et .al (2000) isolated xanthanolide diol derivate ( 11 alpha 13-
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 44
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PHARMACOLOGY 
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 46
 
2. Badam L. et. al (1988) studied the invitro antimalarial activity on ethanolic 
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CHAPTER 3 
AIM AND SCOPE OF THE PRESENT STUDY 
The ethnomedical information of the plant reveals that the leaves of Xanthium 
strumarium linn. were used as antirheumatic, antisyphilitic, diuretic, antitubercular, 
antimalarial, laxative and sedative . According to siddha system of medicine, leaves of this 
plant posseses cardioprotective property. The fruits of this plant were found to possess 
antibacterial and antifungal activities. 
The phytochemical studies on the leaves have been reported for the presence of 
flavanoids, tannins, alkaloids, sterols and carbohydrates. Some phytochemical studies have 
been documented for the presence of phenolic compounds in this plant. 
The cardioprotective and anti-arthritic activities have not yet been reported so far on 
the leaves of Xanthium strumarium.(X.S) 
Hence the present work has been designed in such a way as to carry out the following 
studies on the leaves Xanthium strumarium linn. 
1. Pharmacognostical studies on the leaves. 
2. Preliminary phytochemical screening on the extracts of X.S. 
3. Isolation of phenolic rich fractions from ethanolic extract of  
X.strumarium 
4. Estimation of total phenols, total tannins and total flavanoids. 
5. Phytochemical evaluation of both extract and phenolic rich fraction        
.                    by TLC and HPTLC studies. 
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6. Screening of the ethanolic extract and phenolic rich fraction of the 
leaves for following pharmacological activities. 
 Invitro antioxidants activity 
 DPPH radical scavenging activity 
 Nitric oxide scavenging activity 
 Phosphomolybdenum method 
 Cardioprotective effect of leaf extract of Xanthium strumarium on 
Doxorubicin induced cardiotoxicity in rats. 
 Invitro anti-arthritic activity 
 Antibacterial activity against Streptococcus pryogenes causative 
organism for rheumatic fever and Streptococci viridians, Enterococcus 
faecalis causative organism for endocarditis. 
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CHAPTER - 4 
PHARMACOGNOSTICAL STUDIES 
SECTION – A 
Plant profile 
49,50
 
BIOLOGICAL SOURCE :   Xanthium Strumarium Linn. 
FAMILY                         :    Asteraseae (Compositae) 
 Xanthium Strumarium is a dicotyledonous, monoecious herb. It is a course 
unarmed annual plant upto 1.5 m height and commonly found as weed. 
SYSTEMATIC POSITION: 
Kingdom     : Plantae 
Subkingdom       : Tracheobionta 
Division              : Magnoliopphyta 
Class                : Magnoliopsida 
Subclass             : Asteridea 
Order                 : Asterales 
Family               : Asteraceae 
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Genies              : Xanthium  
Species            : strumarium 
SYNONYM: 
 Xanthium indicum Koen. 
VERNACULAR NAMES: 
English                : Burweed, Clotbur, Cocklebur. 
Hindi                   : Borkra, Gokhru, Chota – gokhru, adhasisi. 
Kannada             : Maruluummatti 
Malayalam         : Buah anjang 
Sanskrit             : Arishta, Shankine. 
Tamil                 : Maruloomatham 
Telugu               : Marulamathangi 
Bengali              : Banokra, Chota – dhatura. 
Marathi             : Dumundi, dutundi. 
Gujaratti           : Gadriyun 
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GEOGRAPHICAL DISTRIBUTION: 
  Cocklebur is probably a native of America. It has become naturalized in India and 
has spread rapidly in several parts of Madhya Pradesh, Maharashtra, at an altitude of 
1500m in Himalayas. Cocklebur was cultivated as a leafy vegetable in china. 
HABIT AND HABITAT: 
 Xanthium Strumarium is an annual herb of about 1.5m tall with short, stout, 
slightly branched stem with short hairs over it. It is distributed in most plain districts on 
waste ground and road sides. Xanthium strumarium has wide distribution because of the 
ease with which its inflorescence is carried about by the feet of the animals and also in 
their wool 
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MORPHOLOGICAL STUDIES ON XANTHIUM STRUMARIUM 
Plant description 
51,52,53
 
Leaves 
 Numerous dark green and alternative leaves of about 5-7cm long and as broad as 
long. Triangular – cordate or suborbicular in shape often three lobed. Irregular toothed 
margin and cuneate apex. Rough with appressed hairs on both sides of the leaves. Petiole 
is 2.5 – 7cm long and hairy. 
 Flowers 
Flower heads are numerous with terminal and axillary racemes. Barren heads are 
numerous and crowded at the top of the stem while fertile heads are fewer and axillary. 
There are few involucral bracts and many inside covered with hooked bristles. There are 
two flowers with no pappus and corolla. 
Fruits 
The fruits are large celled with strong hooks. Achenes are obvoid and closed in 
the hardened involucre . Fruits are pubescent, thickly clothed with hooked prickles and 
about 1.6cm long with two erect mucronate beaks.  
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SECTION - B 
MICROSCOPICAL STUDIES ON THE LEAVES OF  
XANTHIUM STRUMARIUM
 
  
54,55,56
 
COLLECTION OF SPECIMEN 
                    The plant specimens for the proposed were collected from road side of 
Madurai. Care was taken to select healthy plants and normal organs. The required 
samples of leaf were cut and removed from the plant and fixed in FAA (formalin-
5ml+acetic acid-5ml+70%ethyl alcohol-90ml). After 24 hours of fixing, the specimens 
were dehydrated with graded series of tertiary-butyl alcohol as per the schedule given by 
Sauss, 1940. Infiltration of the specimens was carried by gradual addition of paraffin wax 
(melting point 58-60 c) until TBA solution attained super saturation. The specimens were 
cast into paraffin blocks. 
SECTIONING 
                   The paraffin embedded specimen was sectioned with the help of rotary 
microtome. The thickness of the sections was 10-12µm, dewaxing of the sections was by 
customary procedure (Johansen, 1940). The sections were stained with toludine blue as 
per the method published by O’BRIEN et al. (1964). Since toludine blue is a 
polychromatic stain. The staining results were remarkably good; and some cytochemical 
reactions were also obtained. The dye rendered pink colour to the cellulose walls, blue to 
the lignified cells, dark green to suberin, violet to the mucilage, blue to the protein bodies 
etc. wherever necessary sections were also stained with saffranin and fast-green and 
iodine ( for starch) 
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                For studying the stomata morphology, venation pattern and trichome 
distribution, paradermal sections (sections taken parallel to the surface of leaf) as well as 
clearing of leaf with 5% sodium hydroxide or epidermal peeling by partial maceration 
employing  Jeffrey’s  maceration fluid (Sass,1940) were prepared. Glycerin mounted 
temporary preparations were made for macerated/ cleared material. Powdered materials 
of different parts were cleared with sodium hydroxide and mounted in glycerin medium 
after staining. Different cell component were studied and measured. 
PHOTOMICROGRAPHS 
                 Photographs of different magnifications were taken with Nikon lab photo 2 
microscopic units. For normal observation bright field was used. For the study of crystals, 
starch grains and lignified cells, polarized light was employed. Since these structures 
have birefringent property, under polarized light they appear bright against dark 
background. Magnification of the figures were indicated by the scalebars. 
 
1. Leaf: 
The leaf consists of very thick midrib and thin lamina (Fig: 1.1).  The 
midrib is broadly hump shaped on the adaxial side and broadly semicircular on 
the abaxial side.  The midrib is 1.35mm thick, the adaxial hump is 300mm in 
height and 480mm wide.  The abaxial part is 1.2mm wide (Fig; 1.2). 
The midrib consists of uniformly thin epidermal layer of squanesh small 
cells.  Inner to the epidermis are three or four layers of collenchyma cells in the 
adaxial hump as well as abaxial end.  The ground tissue is parenchymatous, the 
cells being large, circular to angular and compact.  Distributed in the ground 
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tissue are small circular secretory canals, with a ring of small epithelial cells (Fig : 
1.2) 
The vascular system of the midrib is multistranded.  There are large 
discrete collateral vascular bundles about five bundles are arranged in a shallow 
are along the abaxial part and one or two bundles located in adaxial part.  The 
vascular bundles have 3-5 parallel lines of circular thick walled xylem elements 
and thick, semicircular cap of phloem elements (Fig : 1.2). 
Lamina (Fig: 2.1-3.3, 1-3) 
The lamina is thin, dorsiventral and amphistomatic (stomata present on both sides 
of the lamina).  The adaxial surface even while abaxial surface has shallow pits in which 
epidermal trichomes are located (Fig : 2.1,2.3).  The adaxial epidermis and abaxial 
epidermis comprises of narrow cylindrical.  The mesophyll tissue is differentiated into 
two adaxial layers of narrow cylindrical, less compact palisade cells and abaxial  zone of 
7-10 layers of small lobed spongy parenchyma cells which form air-chambers (Fig : 2.1, 
2,3).  The lamina is 250µm thick.  The lateral veins do not project much beyond the level 
of the lamina.  The vascular stand of the lateral vein is small and collateral.  It consists of 
adaxial xylem and abaxial phloem, the vascular strands is enclosed by a circular layer of 
parenchymatous bundle sheath with adaxial and abaxial extensions (Fig : 2.3). 
Epidermal Trichomes: 
 Nonglandular and glandular trichomes are seen on both the abaxial and adaxial 
sides of the lamina (Fig : 2.1-3, 3.1).  The nonglandular trichomes are more predominated 
than the glandular type.  The nonglandular trichomes are 2-5 celled, uniseriate, 
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unbranched and thin walled.  The basal cell of the trichome in widest and the cells above 
in the trichome are gradually narrow ending in a pointed end (Fig : 3.2).  The trichomes 
are 140µm in height, the basal cell is 60µm wide and the terminal cell is 10µm wide. 
Glandular trichomes are not much prominent.  They are very small, and delicate, 
dumbshell shaped and 2 celled.  They are situated in shallow pits of the abaxial epidermis 
(Fig : 4.1, 2).  The stalk of the gland is very short.  The gland is 50 µm in horizontal plane 
(Fig ; 6.2). 
Stomata: 
In surface of the paradermal sections, epidermal cells appear small, polygonal 
with slightly wavy anticlinical walls (Fig : 4.1, 4.2, 5.1).  The stomata are dense and 
random in distribution. They are actinocytic type in which a stoma is surrounded by five 
or more radiating triangular subsidiary cells (Fig : 4.12).  The guard cells are elliptical 
with wide stomatal pore.  The stoma is 20x25 µm in size. 
Venation (Fig : 5.12, 6.1): 
 The minor veins that from the areoles are thin with single row of vascular 
elements.  The vascular strand is ensheathed throughout its course by dilated, hyaline 
parenchymatous bundle sheath (Fig : 5.2).  The vein-islets are well defined with distinct 
boundaries.  The islets are narrow, tetragonal to hexagonal in online.  The vein-
terminations are lacking in most of the islets.  When present the terminations are short, 
and less prominent. 
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Petiole: 
 The petiole was studied along the three regions, viz; basal part (Fig : 7.1.2), 
middle part (Fig : 8.2) and terminal part (Fig : 9.1,2,3).  The petiole is circular with 
shallow adaxial depression in the basal and middle parts.  Along the terminal (distal) part 
it is 3 lobed with wide shallow adaxial concavity.  The basal part is 3.1mm thick; the 
middle part is 4mm thick.  The terminal part is less than 4mm thick.  In all three regions 
the petiole has thin discrete epidermal layer followed by four or five layers of 
collenchymas cells and the rest of the ground tissue consists of large thin walled compact 
parenchyma cells.  Secretory canals with epithelial cells are scattered in the ground 
tissue. 
The vascular system exhibits much variation in the three regions of the petiole.  In 
the basal part, these is a large central abaxial vascular strand and an adaxial row of 
comparatively smaller three bundles.  These are also much smaller less prominent 
vascular strands placed in between the major bundles (Fig : 7.1,2). 
 In the middle region are three larger and four smaller bundles arranged in an arc 
(Fig : 8.1).  In  the terminal part, the vascular strands are multiplied forming a lower arc 
of 6 strands and upper arc of 8 strands (Fig : 9.1).  All bundles are collateral with many 
parallel rows of circular wide xylem elements, a thin band of phloem elements and thick 
hemispherical bundle cap sclerenchyma.  Except variation in number and size of the 
vascular strands, the basic type and stomata are similar. 
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SECTION – C 
POWDER ANALYSIS 
In the leaf power are seen small fragments of lamina, epidermal peeling and epidermal 
trichomes. 
 Fragmentary leaf bits exhibit the venation pattern. The venation is densely 
reticulate. The vein are thin with prominent parenchymatous sheath all along the 
veins. The vein-islets are small, polyhedral and well demarcated by distinct vein 
boundaries (10.1,2).this vein terminations are mostly simple, short, branched or 
more commonly unbranched. 
 Epidermal trichomes of nonglandular type are common in this powder. They are 
multicellular walled. The trichome is wider at the base and becomes abruptly 
sharper at the tip. No inclusions are evident in the cells . 
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SECTION – D 
QUANTITATIVE MICROSCOPICAL STUDIES 
57,58
  
DETERMINATION OF LEAF CONSTANTS: 
  The vein islet number, vein termination number, stomatal number and stomatal 
index were determined on fresh leaves by using standard procedures. 
A. Vein islet number and vein termination number: 
The term vein islet is used to denote the minute area of photo synthetic tissue 
encircled by the ultimate division of the conducting strands. The number of vein islets per 
square mm area is called vein- islet number. 
Vein termination number may be defined as the number of vein terminations present 
in one square mm area of the photosynthetic tissue. 
Determination of vein islet number and vein termination number: 
Small pieces of leaves were cut on the lamina between midrib and the margin, 
cleared in chloral hydrate and mounted on a slide.   
Camera Lucida and drawing board were arranged.  With the help of a stage 
micrometer, camera Lucida and microscope, 1mm square was drawn on the paper.  Then 
the stage micrometer was replaced by the sample slides and the veins were traced over 
the square. The vein islets and vein terminations were counted in the square.  Ten such 
readings were taken and the average was calculated and the results were presented in
 
TABLE-1 
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A. Stomatal Number: 
The average number of stomata per square mm area of epidermis of the leaf is 
called stomatal number. 
Determination of Stomatal Number 
Small pieces of upper and lower epidermal peelings of the leaves were mounted 
on a slide.  Camera Lucida and stage micrometer were used to draw 1 mm square was on 
a paper.  The stage micrometer was replaced by the preparation slide. Then the 
preparation were observed under microscope and the stomata were marked in that unit 
area.  Number of stomata present in those unit area were calculated.  Ten such readings 
were taken and the average of stomatal number was calculated and presented in the 
TABLE- for both upper and lower epidermis. 
B. Stomatal Index:  
Definition: 
  It is the percentage which the numbers of stomata form to the total number of 
epidermal cells, each stoma beings counted as one cell.  
Stomatal index           
S.I =
 
   
 ×100 
Where, S=number of stomata per unit area 
             E= number of epidermal cells in the same unit area 
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Determination of Stomatal Index: 
       The procedure adopted in the determination of stomatal number was followed and 
the preparation was observed under high power.  The epidermal cells and the stomata 
were counted.  From these values the stomatal index was calculated using the above 
formula and was given in TABLE-1 
 
Table 1: Quantitative microscopical 
    parameters of the leaf of Xanthium strumarium. 
 
S. No. 
 
Parameters* Values obtained* 
1 Stomatal number  in upper 
epidermis 
103.26  ± 0.12 
2. Stomatal number  in lower 
epidermis 
227.43 ± 0.32 
3. Stomatal index in upper 
epidermis  
17.63 ± 0.34 
4. Stomatal index in lower 
epidermis  
26.54 ± 0.63 
5. Vein islet number 13.49 ± 0.13 
6 Vein termination number 2.63 ± 0.24 
*Mean of 6 readings ± SEM 
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SECTION – E 
PHYSICAL PARAMETERS 
57,59,60,61
 
ASH VALUES: 
   The ash values were determined by using air dried powdered leaves as per the 
official method. 
(A) Total ash: 
   2 grams of the crude leaf powder were accurately weighed in a tarred nickel 
crucible. The ground drug was scattered in a fine even layer on the bottom of the crucible 
and incinerated by gradually increasing the heat not exceeding 450˚ c [dull red heat] until 
free form carbon. Then it was cooled and weighed for constant weight. The percentage of 
ash with reference to the air dried drug were calculated. 
(B) Acid insoluble ash: 
The ash obtained in (A) were boiled for 5 minutes with 25ml of 2M hydrochloric 
acid. The insoluble matter was collected in a tarred sintered glass crucible. The residue 
was washed with hot water, ignited to constant weight, cooled in a desiccators and 
weighed. The percentage of acid insoluble ash with reference to the air dried drug were 
calculated. 
(C)  Water soluble ash: 
  The ash obtained in (A) was boiled with 25ml of distilled water. The insoluble 
matter was collected in a Gooch crucible, washed with hot water ignited to a constant 
weight. Cooled in a desiccators and weighed. The weight of the insoluble matter was 
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subtracted from the weight of  the total ash. The difference gave the weight of the water 
soluble ash. It was calculated with reference to the air-dried powder. The results were 
represented in 
 
TABLE-2 
C. Loss on drying: 
             Loss on drying was determined by the method described by Wallis. 2 grams of 
the powdered crude drug was accurately weighted in a tarred dish and dried in an oven at            
100˚-105  C. It was cooled in a desiccator and again weighed. The loss on drying was 
calculated with reference to the amount of the dried powder taken and presented in 
TABLE -.2
 
Table 2: Analytical parameters of X.strumarium 
S. No Parameters* 
Values* expressed 
as % 
1 Ash values   
 Total ash  11.42  ± 1.34 
 Water insoluble 6.57 ± 0.95 
 Water  soluble ash 4.85 ± 0.74 
 Acid  insoluble ash  2.49 ± 0.62 
2 Loss on drying 2.14 ± 0.31 
* mean of three readings 
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Determination of Extractive values: 
I) Petroleum ether soluble extractive value  
                 5 gm of the air –dried drug, coarsely powdered, was macerated in 100ml of 
petroleum ether in a closed flask for 24 hours, shaking frequently during 6 hrs and 
allowed  stand for 18 hrs, filtered rapidly, taking precautions against loss of solvent. 25ml 
of the filtrate was evaporated to dryness in a tarred flat bottomed shallow dish and dried 
at 105˚ c, to constant weight. The percentage of the petroleum ether soluble extractive 
with references to the air - dried drug was calculated as presented in TABLE-3              
II . Alcohol (Ethanol) and 75% ethanol soluble extractive: 
  5 gm of the air –dried drug, coarsely powdered, was macerated in 100ml of 
ethanol in a closed flask for 24 hours, shaking frequently during 6 hrs and allowed  stand 
for 18 hrs, filtered rapidly, taking precautions against loss of solvent. 25ml of the filtrate 
was evaporated to dryness in a tarred flat bottomed shallow dish and dried at 105˚ c, to 
constant weight. The percentage of alcohol soluble extractive with references to the air - 
dried drug was calculated as presented in TABLE-3 
III). Water-Soluble Extractive: 
5 gm of the air dried drug coarsely powdered, was macerated in 100 ml of 
chloroform water in a closed flask for 24 hours, shaking frequently during 6 hours, and 
allowed to stand for 18 hours. Filtered rapidly, taking precautions against loss of solvent. 
25 ml of the filtrate was evaporated to dryness in a tarred-flat-bottomed shallow dish and 
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dried at 105˚ C to constant weight. The percentage of water – soluble extractive with 
reference to the air-dried drug was calculated and presented in TABLE -3 
IV). Ether soluble Extractive: 
The above mentioned procedure for the determination of petroleum ether soluble 
extractive was followed for the determination of ether soluble extractive also. 
V). Determination of Chloroform, Acetone, methanol and hexane soluble 
extractives: 
 The procedure followed for the determination of alcohol soluble extractive value 
was adopted for the determination of Chloroform soluble extractive, acetone soluble 
extractive, methanol soluble extractive and hexane soluble extractive. Instead of alcohol, 
respective solvents were used for the determination of their extractive values. 
 The percentage of chloroform, acetone, methanol and hexane soluble extractives 
were calculated and presented in TABLE-3 
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Table 3: Extractive values of X.strumarium 
S. No Parameters* Values* expressed 
as % 
 Extractive  values   
     1 Petroleum ether extract            0.4765 
2 Ether extract 3.517 
3 Hexane 3.318 
4 Chloroform 4.015 
5 Acetone 1.559 
6 Methanol 3.289 
7 Ethanol 2.335 
8 75% Ethanol 6.437 
9 Aqueous 5.218 
 
Power analysis 
The behaviour of the X.strumarium powder with various chemical reagents is tabulated in 
table 4 and that of fluorescence analysis of the powder and the extracts of X.strumarium 
are presented in tables 5 & 6. The powder showed the presence of phytosterols, tannins, 
proteins, flavanoids, phenolic compounds. 
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Table 4: Behavior of the X.strumarium powder with various chemical reagents 
Powder + Reagents Colour / Precipitate Presence of active 
principle 
Picric acid Yellow precipitate Protein present 
Conc. sulfuric acid Reddish brown color Phyto sterols present 
Lieberman Burchard reagent Reddish brown color  Phyto sterols present 
Aqueous ferric chloride Greenish black color Tannins present 
Iodine solution No blue color Absence of starch 
Mayer’s reagent Cream color Alkaloids present 
Spot test No stain  Fixed oils absent 
Sulfosalicylic acid  White precipitate Protein present 
Aq. Sodium hydroxide Yellow color Flavanoids present 
Mg – HCl Magenta color Flavanoids present 
Aq. Lead acetate White precipitate Presence of tannins 
Note :-  Colour reactions are viewed under natural light by naked eye 
Table 5:  Fluorescence Analysis of powder of X.strumarium 
Powder +reagent  Day light UV light  
 (254 nm) 
UV light 
 (366 nm) 
Drug powder 
 
Green Green Brown 
Drug powder +aqueous 
1M sodium hydroxide 
Greenish yellow Green Brown 
Drug powder + alcoholic 
1M sodium hydroxide 
Green Green Brown 
Drug powder + iodine Red Green Brown 
Drug powder + 10% 
potassium hydroxide 
Yellowish green  Green Brown 
Drug powder +  1M 
hydrochloric acid 
Green Green Brown 
Drug powder + glacial 
acetic acid 
Green Green Brown 
Drug powder + 50% 
sulphuric acid  
Green Green Brown 
Drug powder + 50% 
nitric acid 
Green Dark green Brown 
Drug powder + 50% 
hydrochloric acid 
Green Green  Brown 
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Table 6:  Fluorescence Analysis of extracts of X.strumarium 
Extracts Consistency Colour in Day 
Light 
Colour under UV Lamp 
366nm 254nm 
Petroleum 
extract 
Semisolid Yellowish green Reddish 
orange 
Green 
Ether extract Semisolid Greenish yellow Brown Green 
Chloroform 
extract 
Semisolid Greenish brown  Orange  Green  
Hexane extract Semisolid Yellowish green Orange  Geeen  
Ethanol extract Semisolid Green Orange  Green  
Methanol extract Semisolid Green Orange  Green  
Aqueous extract Semisolid Greenish  brown Green  Greenish 
brown 
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CHAPTER-5 
SECTION-A 
PHYTOCHEMICAL STUDIES 
                          COLLECTION AND AUTHENTICATION 
The leaves of Xanthium Strumarium were collected in and around Madurai 
and authenticated by taxonomist. The leaves were washed thoroughly and dried in 
shade. The shade dried leaves were powdered and used for further studies.  
                              
ORGANOLEPTIC EVALUATION 
 Nature                - Coarse Powder 
 Colour                - Green 
 Odour                 - no odour 
 Taste                   - acrid 
PRELIMINARY PHYTOCHEMICAL SCREENING 
62,63,64,65
 
1. Test for sterols 
     The powdered leaf was first extracted with petroleum ether and evaporated to a 
residue. Then the residue was dissolved in chloroform and tested for sterols. 
a.Salkowski’s Test 
 A few drops of concentrated sulphuric acid was added to the above solution, 
shaken well and set aside. The lower chloroform layer of the solution turned red in 
color indicating the presence of sterols. 
b. Liebermann – Burchard’s Test 
 To the chloroform solution a few drops of acetic anhydride and 1 ml of 
concentrated Sulphuric acid were added through the sides of the test tube and set aside 
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for a while. At the junction of two layers a brown ring was formed. The upper layer 
turned green indicating the presence of sterols.  
2. Test for Terpenoids 
 A little of the powdered leaf was extracted with chloroform and filtered. The 
filtrate was warmed gently with tin and thionylchloride. Pink color solution appeared 
which indicated the presence of terpenoids. 
3.Test for carbohydrates 
a.Molisch’s Test: 
 The aqueous extract of the powdered leaf when treated with alcoholic solution 
of α-naphthol in the presence of sulphuric acid gave purple color indicating the 
presence of carbohydrates. 
b.Fehling’s Test: 
 The aqueous extract of the powdered leaf was treated with Fehling’s solution I 
and II and heated on a boiling water bath for half an hour. Red precipitate was 
obtained indicating the presence of free reducing sugars. 
4. Test for Flavonoids 
a. Magnesium turning- con HCl test: 
        A  little of the powdered drug was heated with alcohol and filtered. To the test 
solution magnesium turnings and few drops of concentrated hydrochloric acid were 
added. Boiled for five minutes. Red colour was obtained indicating the presence of 
flavonoids. 
b.Alkali Test 
       To the small quantity of test solution 10% aqueous sodium hydroxide Solution 
was added.  Yellow orange color was produced indicating the presence of flavonols.  
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C.Acid Test 
To the small quantity of test solution, few drops of concentrated Sulphuric 
acid was added. Yellow orange color obtained indicates the presence of flavonols. 
7. Test for Proteins 
a.Millon’s Test  
A small quantity of aciduous – alcoholic extract of the powdered drug  was 
heated with Millon’s reagent. White precipitate turned red on heating Indicated the 
presence of proteins.  
b. Biuret Test  
           To one portion of aciduous – alcoholic extract of the powdered drug one ml of 
10% sodium hydroxide solution was added, followed by this one drop of dilute copper 
sulphate solution was added. Violet color was obtained indicating the presence of 
proteins. 
8. Test for Alkaloids 
a. About 2gm of the powdered material was mixed with 1gm of calcium 
hydroxide and 5ml of water into a smooth paste and set aside for 5 minutes. It was 
then evaporated to dryness in a porcelain dish on a water bath. To this 200ml of 
chloroform was added, mixed well and refluxed for half an hour on a water bath. 
Then it was filtered and the chloroform was evaporated. To this 5ml of dilute 
hydrochloric acid was added followed by 2ml of each of the following reagents. 
a) Mayer’s Reagent                 _       cream precipitate 
b) Dragendorff’s Reagent        _      orange brown precipitate 
c) Hager’s Reagent                  _       Yellow precipitate  
d) Wagner’s Reagent               _        Reddish brown precipitate 
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b. Test for purine group (Murexide test) 
                The residue obtained after the evaporation of chloroform as described in (a) 
was treated with 1ml of hydrochloric acid in a porcelain dish and 0.1gm of Potassium 
chlorate was added and evaporated to dryness on water bath. Then the residue was 
exposed to the vapour of dilute ammonia solution. No purple Color was obtained 
indicating the absence of purine group of alkaloids. 
Test for Glycosides 
Borntrager’s Test 
            The powdered leaf was boiled with dilute sulphuric acid, filtered and to the 
filtrate, benzene was added and shaken well. The organic layer was separated to 
which ammonia solution was added slowly. 
                No color reaction observed in ammoniacal layer showing the absence of 
Anthraquinone glycosides. 
Modified Borntrager’s Test 
              About   0.1g of the powdered drug was boiled for 2minutes with dilute 
hydrochloric acid and few drops of ferric chloride solution, filtered while hot and 
cooled. The filtrate was then extracted with benzene and the benzene layer was 
separated. Equal volume of dilute ammonia solution was added to the Benzene 
extract. 
                 No pink color was observed in ammoniacal layer showing the absence of 
anthraquinone  glycosides. 
Test for Cardiac Glycosides(for deoxysugar) 
Keller Kiliani Test 
          About 1g of the powdered leaf was boiled with 10ml of 70% alcohol for 2 
minutes, cooled and filtered. To the filtrate 10ml of water and 5 drops of solution of 
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leadsubacetate were added and filtered, evaporated to dryness. The residue was 
dissolved in 3 ml of glacial acetic acid. To this 2 drops of ferric chloride solution was 
added. Then 3 ml of concentrated sulphuric acid was added to the sides of the test 
tube carefully and observed. 
               No reddish brown layer was observed indicating the absence of deoxysugars 
of cardiac glycoside 
Test for Cyanogenetic Glycosides 
               Small quantity of the powder was placed in a stoppered conical flask with 
just sufficient water, to cover it. A sodium picrate paper strip was inserted through the 
stopper so that it was suspended in the flask and it was set aside for 2 hours in a warm 
place. 
                No brick red color was produced on the    paper indicating the absence of 
Cyanogenetic glycosides. 
Test for saponins  
              About 0.5g of the powdered drug was boiled gently for 2 minutes with 20ml 
of water and filtered while hot and allowed to cool. 5 ml of the filtrate was then 
diluted with water and shaken vigorously.  Frothing was produced indicating the 
presence of saponins. 
Test for Tannins  
           A small quantity of the powdered drug was extracted with water. To the 
aqueous extract few drops of ferric chloride solution was added. 
      Bluish black color was produced indicating the presence of tannins. 
Test for the presence of Volatile oil 
Weighted quantity (250 gm) of fresh leaves were extracted the subjected to 
hydrodistillation using volatile oil estimation apparatus (BP 1980). 
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           volatile oil was obtained indicating the presence of volatile oil 
TABLE: 4  PRELIMINARY PHYTOCHEMICAL SCREENING FOR THE 
LEAF POWDER OF  XANTHIUM STRUMARIUM 
S.NO                                TEST RESULTS 
1. TEST FOR STEROLS  
 a. Salkowski’s test + 
 b. Libermann- burchard’s test + 
2. TEST FOR CARBOHYDRATES  
 a. Molisch’s test + 
 b. Fehling’s test + 
 c. Benedict’s test + 
3. TEST FOR PROTEINS  
 a. Millon’s test + 
 b. Biuret test + 
4. TEST FOR ALKALOIDS  
 a. Mayer’s reagent + 
 b. Dragendroff’s reagent + 
 c. Hager’s reagent + 
 d. Wagner’s reagent + 
5. TEST FOR GLYCOSIDES  
 a. Anthraquinone glycosides  
     i) Borntrager’s test - 
     ii) Modified Borntrager’s test - 
 b. Cardiac glycosides  
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     i) Keller Killiani test  - 
 c. Cyanogenetic glycosides - 
6. TEST FOR SAPONINS + 
7. TEST FOR TANNINS  
 Fecl3 test  + 
8. TEST FOR FLAVONOIDS  
 a. Shinoda test + 
 b. Alkali test + 
 c. Acid test + 
9. TEST FOR TERPENOIDS + 
10. TEST FOR VOLATILE OILS + 
 
       (+) indicates positive reaction                 (-) indicates negative reaction   
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TABLE-5                                                                                               
PRELIMINARY PHYTOCHEMICAL SCREENING FOR THE VARIOUS 
EXTRACTS OF LEAF POWDER OF XANTHIUM STRUMARIUM 
Tests Pet.ether 
Extract 
Ether 
Extract 
Hexane 
Extract 
Chloroform 
Extract 
Acetone 
Extract 
Methanol 
Extract 
Ethanol 
Extract 
Ethanol 
extract 
(75%) 
Aqueou
s 
 extract 
I  sterols   
Salkowski’
s test 
+ + + + + - - - - 
Libermann
- 
burchard’s 
test 
+ + + + + - - - - 
II. Test for Carbohydrates 
Molisch’s 
test 
- - - - - + + + + 
Fehling’s 
test 
- - - - - + + + + 
Benedict’s 
test 
- - - - - + + + + 
III.Test for Proteins 
Millon’s 
test 
- - - - - + + + + 
 Biuret test -  - - - + + + + 
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IV.Test for Alkaloids 
Mayer’s 
reagent 
- - - - - + + + + 
Dragendrof
f’s reagent 
- - - - - + + + + 
 Hager’s 
reagent 
- - - - - + + + + 
Wagner’s 
reagent 
- - - - - + + + + 
V.Test for Glycosides 
Anthraquin
one 
glycosides 
-  - - - - - - - 
    i) 
Borntrager
’s test 
-  - - - - - - - 
    ii) 
Modified 
Borntrager
’s test 
-  - - - - - - - 
 Cardiac 
glycosides 
         
    i) Keller 
Killiani 
test  
- - - - - - - - - 
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(+) indicates positive reaction                 (-) indicates negative reaction    
 
 
 
 
 
 
 
Cyanogene
tic 
glycosides 
- - - - - - - - - 
VI.Test 
for 
Saponins 
- - - - - + + + + 
VII.Test for Tannins 
Fecl3 test  - - - - + + + + + 
VIII.Test for Flavonoids 
Shinoda 
test 
- - - - + + + + + 
Alkali test - - - - - + + + + 
Acid test - - - - - + + + + 
IX.Test 
for 
Terpenoid 
+ + + + + + + + - 
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SECTION-B 
PREPARATION OF EXTRACT 
About 1kg of the dried powdered leaf of Xanthium Strumarium was defatted 
with 2.5 litres petroleum ether (60-80
0
 C) by maceration.  The solvent was removed 
by filtration and the marc is dried.  To the dried marc 2.5 litres of 75% ethanol was 
added and the extraction was performed by triple maceration.  It was then filtered and 
the combined filtrate was evaporated to a cohesive mars using rota vapour. 
ISOLATION 
Numerous beneficial effect attributed to phenolic products have given such to an 
interest in finding botanical species with high phenolic contents and relevant 
biological activity 
ISOLATION OF PHENOLIC RICH FRACTION 
66 
Ethanolic extract was fractionated with different solvents of increasing polarity viz 
hexane, chloroform, ethylacetate, n-butanol and water.  Phenolic fractions obtained 
from the above solvents were concentrated under reduced pressure which gave a 
residue. 
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FLOW CHART OF PREPARATION OF PHENLIC RICH FRACTION 
Leaves powder 
                                                                  Extracted with 75%ethanol in water 
 
75%ethanol Extract 
                                                     Dissolved in Distilled water 
Aqueous and ethanol Extract  
                                                  Extracted with Hexane; thrice 
           
 
Hexane Fraction                         Remaining Extract 
Extracted with 
chloroform   
thrice         
 
  
                                        
             Chloroform Fraction                                     Remaining extract 
      Extracted with          
      Ethyl Acetate         
      thrice 
 
                                                   
  Ethyl Acetate Fraction          Remaining Extract 
                                                                                                                 Extracted with        
                                                                                                                n-Butanol thrice 
                                                                   
                                                                 n-Butanol Fraction             Remaining Extract 
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SECTION-C 
TOTAL PHENOL, TOTAL TANNIN, TOTAL FLAVANOID  
DETERMINATION
 67,68 
 
TOTAL PHENOL DETERMINATION  
 PRINCIPLE 
 Total phenolic content of the various extracts of X. Strumarium were 
determined  by Folin Ciocalteu reagent method. 
            All the phenolic compounds are oxidised by the Folin-Ciocalteu Reagent. This 
reagent, which is reduced during oxidation of the phenolic substances, into a mixture 
of blue molybdenum and tungsten oxides. 
                  The blue colour produced has a maximum absorption at about 750-760nm. 
The absorption is proportional to the quantity of oxidised phenolic compounds. 
 
REAGENTS REQUIRED  
a) Folin Ciocalteu Reagent (1N) 
         Commercially available Folin Ciocalteu Reagent (2N) was diluted with 
an equal volume of distilled water. The resultant solution was kept in a brown 
color bottle and stored in refrigerator at 4 ºc. 
b) Sodium carbonate solution (10%) 
c) Standard gallic acid solution. 
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PROCEDURE. 
             1ml of (1mg/ml)  ethanolic extracts of  X.  Strumarium  (EXS and EAXS) 
were taken in separate test tube. Add 0.5ml of Folin Ciocalteu reagent (1N) and 
allowed to stand for 15 mins. Then 1ml of 10% sodium carbonate solution was added. 
Finally the mixtures were mixed with distilled water and made upto 10ml, allowed to 
stand for 30 minutes at room temperature and total phenols were determined by 
spectrophotometrically at 760nm. 
             The calibration curve was generated by preparing Gallic acid at different 
concentration (2,4,6,8,10µg/ml). The reaction mixture without sample was used as 
blank. Total phenol content of various leaf extracts are expressed in terms mg of 
Gallic acid equivalent per gm of extract (mg GAE/g) in table 6 
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Table-6 ESTIMATION OF TOTAL PHENOL CONTENT OF X. 
STRUMARIUM 
 
*mean of three readings±SEM 
 
 
 
 
 
 
 
STANDARD ABSORBANCE         TEST ABSORBANCE TOTAL 
PHENOL 
CONTENT 
sample Conc.in 
µg/ml 
 Sample Conc 
in 
µg/ml 
 Mg of GAE/gm 
of extract 
Gallic 
acid 
2 
4 
6 
8 
10 
0.148 ± 0.01 
0.325 ± 0.03 
0.502 ± 0.02 
0.813 ± 0.03 
0.823 ± 0.01 
EXS 
PHENOLIC 
RICH 
FRACTION  
Hexane 
Chloroform 
Ethylacetate 
n-butanol 
100 
 
 
 
100 
100 
100 
100 
2.535 ± 0.3 
 
 
 
2.102 ± 0.5 
1.954 ± 0.3 
3.227 ± 0.2 
1.732 ±0.3 
221.9 ± 0.76 
 
 
 
181.9 ± 0.6 
168.7 ± 0.50 
278.6  ± 0.49 
149.6 ± 0.73 
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Fig-11: Calibration curve of Gallic acid 
 
 
 
TOTAL TANNIN DETERMINATION
67,69
 
PRINCIPLE  
 Total tannin content of ethanolic extracts of X.strumarium was determined by 
Folin Denis reagent method.                
           Tannin like compounds reduces phosphotungstomolybdic acid in alkaline 
solution to produce a highly coloured blue solution. The intensity of which is 
proportional to the amount of tannins. The intensity is measured in a spectrometer at 
700nm 
 
 
 
 
y = 0.0921x - 0.0284 
R² = 0.994 
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Conc. in mcg/mL 
Calibration curve of gallic acid 
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REAGENTS REQUIRED 
a) Folin Denis Reagent ( sodium tugstate 100g and phospho molybdic acid  
20gm were dissolved in distilled water 750ml along with phosphoric 
acid 50ml. The mixture was refluxed for 2 hours and volume was made 
upto 1 litre with distilled water )  
b) Sodium carbonate solution (10%) 
c) Standard tannic acid solution. 
 
PROCEDURE 
           0.2ml of (1mg/ml) ethanolic extracts of X. stramarium   was taken in a separate 
test tubes and mixed with distilled water to made upto the volume of 1ml. Then add 
0.5ml of Folin Denis reagent and allowed to stand for 15 mins, then  1ml of sodium 
carbonate solution was added and  the mixture was mixed with distilled water and 
made upto  10ml, allowed to stand for 30mins at room temperature and the tannin 
content was determined spectrophotometrically at 700nm.  
The calibration curve was generated by preparing tannic acid at different 
concentration (4, 8, 12, 16, 20µg/ml). The reaction mixture without sample was used 
as blank. The total tannin content in the various leaf extract was expressed as 
milligrams of tannic acid equivalent per gm of extract. 
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TABLE-7 : ESTIMATION OF TOTAL TANNIN CONTENT 
STANDARD ABSORBANCE TEST ABSORBANCE TOTAL 
TANNIN 
CONTENT 
sample Conc.in 
µg/ml 
 sample Conc 
in 
µg/ml 
 
 
Mg of 
tannic 
acid/gm of 
extract 
 
 
Tannic 
acid 
4 
8 
12 
16 
20 
 
0.098 ± 0.02 
0.183 ± 0.01 
0.203 ± 0. 01 
0.361 ± 0. 2 
0.451 ± 0. 1 
 
 
EXS 
 
 
20 
 
 
 
 
0.147 ± 0.02 
 
 
 
 
327 ± 0.72 
mean of three readings±SEM 
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Fig-12: calibration curve for tannic acid 
 
 
TOTAL FLAVANOIDS CONTENT 
70,71,72
  
PRINCIPLE 
The aluminum chloride colorimetric technique was used for estimation of total 
flavonoid estimation . Aluminum ions form stable complexes with C4 keto group and 
either to C3 or C5 hydroxyl groups of flavones and flavonols in acidic medium. It also 
forms acid labile complexes with ortho hydroxyl groups in the A or B rings of 
flavanoids . These complexes showed a strong absorption at 415nm which is used for 
the estimation of flavanoids.  
INSTRUMENT 
 Shimadzu UV Visible spectrophotometer, Model 1800 
REAGENTS  
10% aluminum chloride 
1M potassium acetate 
y = 0.0224x + 0.0038 
R² = 0.9997 
0
0.05
0.1
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Conc. in mcg/mL 
Calibration curve for tannic acid 
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PROCEDURE  
An aliquot quantity of quercetin  was dissolved in ethanol to get a stock 
solution of 1mg/mL. Further dilutions were made to get concentrations ranging from 
20-100µg/mL. 1ml of the above standard solutions were taken in different volumetric 
flasks, 0.1mL of aluminum chloride solution, 0.1mL of potassium acetate solution and 
2.8mL of ethanol were added and the final volume was then made up to 5mL with 
distilled water. After 20min the absorbance was measured at 415nm. A sample 
without aluminium chloride was used as a blank. From the absorbance obtained, a 
calibration curve was constructed by plotting concentration versus absorbance of 
quercetin (Fig.13). 1mL of methanolic extract at concentrations 40µg/mL and 
80µg/mL were taken and the reaction was carried out as above and the absorbance 
was measured at 415nm after 20min and the readings were tabulated in Table 8. The 
amount of flavonoids present can be determined by linear regression analysis. The 
total flavonoid content was expressed as mg querecetin equivalents /g of extract. 
 
 
 
 
 
 
 
 
 
 
PHYTOCHEMICAL STUDIES 
 
Department of Pharmacognosy, MMC. 60 
 
 
              TABLE-8 : ESTIMATION OF TOTAL FLAVANOID CONTENT 
STANDARD 
ABSORBANCE 
TEST 
ABSORBANCE 
TOTAL 
TANNIN 
CONTENT 
sample 
Conc.in 
µg/ml 
sample 
Conc in 
µg/ml 
Mg of 
tannic 
acid/gm of 
extract 
1 
 
2 
 
3 
 
4 
 
5 
20 
 
40 
 
60 
 
80 
 
100 
0.589 ± 0.01 
1.151 ± 0.04 
1.710 ± 0.09 
2.390 ± 0.03 
3.112 ± 0.03 
 
 
 
 
EXS 
 
 
 
 
 
100 
 
200 
 
0.027±0.02 
 
0.092 ± 0.01 
 
22.015±0.5 
 
23.03±0.2 
mean of three readings±SEM 
 
 
 
 
 
 
PHYTOCHEMICAL STUDIES 
 
Department of Pharmacognosy, MMC. 61 
 
 
Fig: Calibration curve of quercetin 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Calibration curve of quercetin
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SECTION-D  
TLC AND HPTLC STUDIES 
73,74
 
 
The phytochemical evaluation of ethanolic extract of Xanthium strumarium 
and phenolic rich fraction of X.S. was carried out using TLC and HPTLC studies. 
 
DEVELOPMENT OF CHROMATOGRAMS 
The extracts were dissolved in ethanol and the spot was applied on the TLC 
plates using capillary tube. 
The plates were developed in the chromatographic tank containing the solvent 
systems.  Various solvent systems were tried for better results.  The TLC plates were 
allowed to develop upto 2/3
rd
 of the plate length and dried.  The TLC plates were 
examined visually or under UV light. 
 Stationary phase - silicagel G 
 Mobile phase   - Toluene : Ethylacetate : Formic acid 
      7:3:02 
 Detecting agent        - visual & UV light  
The Rf  value of the spots obtained were calculated using the formula, 
                        Distance travelled by solute 
  Rf  value =    ------------------------------------ 
              Distance travelled by solvent 
 
The TLC plates when examined after using different detecting agents showed 
the presence of different active principles in both EXS and EAXS. The spots  showed 
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fluorescence when viewed under UV light. The active principle at Rf value 0.07 may 
be responsible for the antioxidant activity due to its phenolic nature. 
 
Table 9: Phytochemical evaluation of ethanolic exract and phenolic rich fractions 
by TLC studies. 
S.NO SOLVENT 
SYSTEM 
EXTRACT NO. OF 
SPOTS 
RF 
VALUE 
DETECTING 
AGENT 
 1.  
 
 
 
 
 
 
TOLUENE : 
ETHYLACETATE: 
FORMIC ACID 
7 : 3 : 0.2 
 
EXS 
 
  3 
0.7 
0.8 
0.9 
 
 
 
 
 
 
 
UV -  366 
 Phenolic rich 
fraction 
 
2  
Hexane 
 
3 
0.71 
0.81 
0.89 
3  
Chloroform 
 
3 
O.4 
0.52 
0.75 
4  
Ethylacetate 
 
3 
0.39 
0.63 
0.72 
5  
N-butanol 
 
1 
 
0.56 
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HPTLC PROFILE: 
Instrument used : CAMAG make HPTLC. 
Software  : winCATS 1.4.3 
Sample Applicator : Linomat 5. 
Detection            : @254nm & @366nm in Densitometry TLC Scanner 3 
Sample preparation : The sample was prepared in corresponding solvents  
Stationary Phase : HPTLC plates silica gel 60 F 254. 
Mobile Phase  : Toluene: Ethyl acetate: Formic Acid (7:3:0.2)  
Sample  : Track 1: EXS , Track 2:EA XS  
 
FINGERPRINTING:    
3D DISPLAY 
@ 254nm        @366nm 
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TABLES:10 HPTLC chromatogram of both EXS and EAXS at 254nm 
 
 
 
 
 
 
 
 
 
 
TABLES:11 HPTLC chromatogram of both EXS and EAXS at 366nm 
 
 
 
 
 
 
 
 
 
 
 
Peak 
@ 254nm 
Track 1 Track 2 
Rf value Area  (AU) Rf value Area  (AU) 
1 0.09  949.1  0.08  396.8  
2 0.13  192.9  0.12  714.3  
3 0.16  533.6  0.15  256.0  
4 0.20  160.1  0.23  1657.4  
5 0.26  258.2  0.31  1543.5  
6 0.31  3974.0  0.40  1317.8  
7 0.40  814.9  0.60  955.4  
8 0.60  1279.1  0.88  1083.6  
9 0.78  457.5  0.96  1126.5  
10 0.88  993.7  1.02  446.7  
11 0.96  1411.4    
Peak 
@366nm 
Track 1 Track 2 
Rf value Area  (AU) Rf value Area  (AU) 
1 0.12  803.1  0.08  131.7  
2 0.17  488.4  0.12  638.5  
3 0.21  637.7  0.24  609.3  
4 0.30  1241.6    
5 0.38  2419.9    
6 0.53  1135.2    
7 0.60  1011.1    
8 0.64  3053.2    
9 0.79  1370.5    
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CHAPTER - 6   
PHARMACOLOGICAL SCREENING   
PART I 
INVITRO ANTIOXIDANT ACTIVITY  
 
Antioxidants play an major role in the treatment of various diseases. It has 
been reported in many studies that the antioxidant property of the plants may due to 
the presence of phenolic compounds. The natural antioxidants are ascorbic acid, 
vitamin E, phenolic acids etc. The antioxidants scavenge the free radical generated, 
due to oxidative stress and exhibit a protective effect against many diseases like 
cancer, cardiovascular disease, diabetes and ageing. Some of the in vitro models for 
the evaluation of antioxidant activity are listed below
72 
 DPPH method 
 Superoxide radical scavenging activity 
 Hydroxyl radical scavenging activity 
 Nitric oxide radical inhibition assay 
 Reducing power method 
 Phosphomolybdenum method 
 Peroxy nitrile radical scavenging activity 
 Xanthine oxidase method 
 Ferric reducing ability of Plasma 
 Thiobarbituric acid assay etc. 
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 Diphenyl picryl hydrazyl (DPPH) method 
75,76,77
 
Principle:  
 DPPH is a stable free radical with a distinctive ESR signal. Its reaction with 
antioxidants can be followed by the loss of absorbance at 517nm.  It is widely 
accepted that DPPH accept an electron or hydrogen radical and become a stable 
diamagnetic molecule. Due to its odd electron, the ethanol solution of DPPH (purple 
colour solution) shows a strong absorption at 517nm. DPPH radicals react with 
suitable reducing agents where the pairing of electrons takes place and the solution 
loses colour stochiometrically with the number of electrons taken up. 
DPPH
.
  + AH →  DPPH-H  +  A. 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
0.1mM diphenyl picryl hydrazyl in ethanol 
Procedure 
A stock solution of DPPH was prepared in ethanol (4mg/100ml). To the 1mL 
of test samples of different concentrations (EXS and EAXS), 4mL of DPPH was 
added. Control without test compound was prepared in an identical manner. Blank 
was prepared in the similar way, where DPPH was replaced by ethanol. The reaction 
was allowed to be completed in the dark for about 30min. Then the absorbance of test 
mixtures was read at 517nm. The percentage inhibition was calculated and expressed 
as percent scavenging of DPPH radical. Vitamin C was used as standard. 
 The percentage scavenging was calculated using the formula 
%inhibition = [(Control-Test)/Control] x 100 
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 The concentration of the sample required for 50% reduction in absorbance 
(IC50) was calculated using linear regression analysis. The results obtained are 
presented in Table 12 and Fig. 15 
 Nitric oxide scavenging activity assay 
78,79 
Principle  
Nitric oxide scavenging activity was determined according to the method 
reported by Green et al., 1982 [78]. Sodium nitropruside in aqueous solution at 
physiological pH spontaneously generates nitric oxide, which interact with oxygen to 
produce nitrite ions. These nitrite ions can be determined by Griess Illosvoy reaction. 
The nitrite ions produced diazotizes sulphanilamide and the diazonium salt thus 
obtained reacts with NN naphthyl ethylene diamine dihydrochloride to give a pink 
colour chromophore which has a maximum absorption at 546nm.  
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
10mM sodium nitroprusside 
Phosphate buffered saline pH 7.4 
2% sulphanilamide in ortho phosphoric acid 
0.1%  naphthyl ethylene diamine dihydrochloride  
Procedure  
To 1mL of sodium nitroprusside, 2.5mL phosphate buffered saline pH 7.4 was 
added.  1mL of extracts at various concentrations were added to the above solution 
and the mixture was incubated at 25
o
C for 30min. To 1.5mL of the incubated mixture 
add 1mL of sulphanilamide in phosphoric acid and 0.5mL of naphthyl ethylene 
diamine dihydrochloride. The absorbance was measured at 546nm. Ascorbic acid was 
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used as a standard. The percentage inhibition of nitric oxide radical generated was 
calculated using the following formula:  
% inhibition = [(Control-Test)/Control] x 100.  
The IC50 was calculated using linear regression analysis. The results wewe presented 
in Table 13 and Fig..16 
 
 Total antioxidant activity by phosphomolybednum method 
80
 
Principle 
This is a spectrophotometric method. The assay is based on the reduction of 
Mo(VI) to Mo(V) by the sample and by the subsequent formation of green phosphate 
Mo(V) complex at acidic pH which has a maximum absorption at 695nm.. This 
method is routinely used to determine total antioxidant activity of samples. 
Mo
6+         →        Mo5+ 
Instrument 
 Shimadzu UV Visible spectrophotometer, Model 1800 
Reagents 
0.6M sulphuric acid   
28mM sodium phosphate 
4mM ammonium molybdate 
Procedure 
An aliquot of 0.3ml of different concentrations of sample solutions was 
combined with 2.7ml of the reagent solution (H2SO4, sodium phosphate and 
ammonium molybdate). 0.3mL of methanol was used in place of sample for control. 
The tubes were incubated in a boiling water bath at 95°C for 90min. After the samples 
had cooled to room temperature, the absorbance was measured at 695nm against 
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blank. The standard vitamin C was treated in a similar manner. The antioxidant 
activity was expressed as equivalents of Vitamin C (µg/g). The results are tabulated in 
Table14 and Fig.17 
 
Table 12: Free radical scavenging activity of EXS, EAXS by DPPH 
assay 
S. No. Conc. 
in 
μg/mL 
Percentage 
inhibition by 
standard 
ascorbic acid 
Percentage 
inhibition by 
EXS 
Conc. in 
μg/mL 
Percentage 
inhibition by 
EAXS 
1 20 25.86  38.56 5 43.86 
2 40 53.32  47.21 10 54.24 
3 60 62.2  59.76 15 65.87 
4 80 81.21  65.42 20 73.36 
5 100 93.73  78.12  25 85.20 
 IC50 47.06 μg/mL 52.65 μg/mL IC50 11.25 μg/mL 
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Fig. 15: Free radical scavenging of EXS against DPPH 
 
 
 
 
 
 
Table 13: Percentage inhibition of ethanolic extract of X. strumarium                      
against  nitric oxide. 
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S. No. Conc. in 
μg/mL 
Percentage 
inhibition by 
standard ascorbic 
acid* 
Percentage 
inhibition by 
EXS* 
1 44.44 55.71 ± 0.45 36.51 ± 2.39 
2 88.89 58.94 ± 0.38 49.77 ± 1.50 
3 133.33 76.61 ± 3.13 65.01 ± 0.21 
4 177.78 78.27 ± 2.56 70.39 ± 0.04 
5 222.22 80.03 ± 1.97 74.08 ± 0.38 
 IC50 84.64 μg/mL 113.48 μg/Ml 
 
*mean of three readings ± SEM 
 
Fig. 16: Nitric oxide radical scavenging by ethanolic extract of X.strumarium 
 
 
Table 14: Total  antioxidant activity of Ethanolic extract of X. strumarium 
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S.No. Conc. in 
µg/mL 
Abs. of standard 
ascorbic acid* 
Conc. in 
µg/mL 
Abs. of EXS* 
1 16.67 1.165 ± 0.006 16.67 0.828 ±0. 008 
2 33.33 2.350 ± 0.001 33.33 1.593 ± 0.003  
3 50 3.515 ± 0.004 50 1.906±0.007 
*mean of three readings ± SEM 
 
Figure17 : Total  antioxidant activity of Ethanolic extract of X. strumarium 
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CARDIOPROTECTIVE EFFECT OF LEAF EXTRACT OF XANTHIUM 
STRUMARIUM ON DOXORUBICIN INDUCED CARDIOTOXICITY IN 
RATS 
81,82,83,84,85
 
Cardiotoxicity was induced in rats using doxorubicin. Though doxorubicin is a 
potential antineoplastic drug its therapeutic spectrum is narrowed due to its 
cardiotoxic side effects. Administration of the doxorubicin at 15mg/kg body weight of 
albino rats leads to cardiomyopathy and heart failure. 
MATERIALS AND METHODS: 
ANIMAL: 
Male albino rats (150-200g) were procured from the central animal 
house, Institute of Pharmacology, Madurai medical college, and also from an 
approved supplier (License No:  ) The animals were housed under standard conditions 
of temperature (25
o 
± 2
o
 C) and photoperiod of 12 hours dark/light cycle with food 
and water at libidum.  The institutional animal ethical committee clearance was 
obtained and the experimental study was conducted according to the protocol 
approved by them. 
CHEMICALS AND REAGENTS 
 CK-MB DIAGNOSTIC KIT 
 LDH DIAGNOSTIC KIT 
 TRIS HCL BUFFER 
 THIOBARBITURIC ACID (TBARS) 
 DTNB REAGENT 
 
 
CARDIOTOXICITY INDUCING AGENT: 
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Doxorubicin (DOXIGLAN),the cardiotoxic agent was purchased from Gland 
pharma limited.  This drug was reconstituted with sterile water for injection and used 
for this study.  Doxorubicin at a dose of 15mg/kg was administered intraperitoneally 
to rats in order to reduce cardiotoxicity. 
EXPERIMENTAL PROTOCOL: 
The animals were divided into 5 groups and each group consists of six animals 
(n=6).  Group I and II animals were administered 1% CMC alone while group III and 
IV animals were administered with ethanolic extract of Xanthium strumarium - EXS 
(as a suspension in 1% CMC) at 100mg/kg and 200mg/kg doses respectively. Group 
V animals were administered the phenolic rich fraction of Xanthium strumarium - 
EAXS (10mg/kg) for five consecutive days by oral route.  On the fifth day,  group III, 
IV, V animals were administered extracts an hour prior to the administration of 
doxorubicin  
GROUP  TREATMENT 
I 1% CMC in distilled water for five consecutive days 
orally 
           II                              Single dose for Doxorubicin at 15mg/kg IP was     
administered on
 
fifth day alone. 
III                                 EXS at 100mg/kg PO was administered for consecutive  
days and Doxorubicin 15mg/kg IP on the fifth day 
alone.  
IV   EXS at 200mg/kg PO was administered for five  
Consecutive days and Doxorubicin 15mg/kg IP on the 
fifth day alone 
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V   EXS at 200mg/kg PO was administered for consecutive  
 days and Doxorubicin 15mg/kg IP on the fifth day 
alone. 
   After 24 hours of doxorubicin administration blood samples were collected. 
All the animals were sacrificed as per the CPCSEA guidelines. Heart was isolated and 
used for Histopathological and antioxidant studies. 
PARAMETERS EVALUATED: 
 Serum parameters 
CK - MB and LDH 
 Estimation of invivo antioxidants in cardiac tissue  homogenate                             
TBARS, GSH and Total protein. 
 Histopathological studies. 
 
ESTIMATION OF INVIVO ANTIOXIDANTS 
PREPARATION OF TISSUE HOMOGENATE 
The isolated heart was washed and blotted in a filter paper.  A 10% tissue 
homogenate was prepared by using chilled 0.15M Tris Hcl (P
H 
 7.4) buffer and 
centrifuged at 5000rpm for 5minutes. The clear supernatant liquid was used for the 
estimation TBARS, GSH and total protein. 
 
 
 
ESTIMATION OF LIPID PEROXIDATION (TBARS): 
Lipid peroxidation was estimated by the method described by Rajkumar D.V. et al. 
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To 1ml of the tissue homogenate, 2.5ml of trichloroacetic acid (20%) were 
added and centrifuged.  2.5ml of 0.05M sulphuric acid and 3.5ml thiobarbituric acid 
were added to the supernatant liquid and incubated at 37
o
C for 30minutes.  It was then 
extracted with n-butanol.  Intensity of the chromogen in the layer was measured at 
530nm using UV spectrophotometer. The were presented in the table 16. Fig 19  
 
ESTIMATION OF REDUCED GLUTATHION: 
Reduced Glutathione was estimated by the method described by Morn et al.,(1979) 
    1 ml of tissue homogenate was precipitated with 1 ml of 10 % TCA and was 
centrifuged to    remove the precipitate. To 0.5 ml of the supernatant added 2 ml of 
0.6 mM 5,5’Dithiobis-2-nitrobenzoic acid(DTNB) in 0.2 M Sodium phosphate and 
the total volume was made upto 3 ml with 0.2 M Phosphate buffer (pH 8).  The 
absorbance was read out at 412nm. The results    obtained were presented in table 16. 
Fig 19 
 
 
 
 
 
 
 
 
 
Table 15: Effect of  EXS and EAXS on serum biochemical parameters 
Groups CK-MB LDH 
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Values expressed as mean SEM *p<0.001 when compared with Doxorubicin 
Digits in parentheses indicate dose in mg/kg 
CK-MB – Creatine kinase - MB, LDH – Lactate dehydrogenase 
EXS        Ethanolic extract(75%) of  Xanthium strumarium 
EAXS      Ethylaectate fraction of Xanthium strumarium.   
Table 16: Effect of  EXS and EAXS on tisssue biochemical parameters. 
 
 
 
 
 
 
 
 
  
   Values expressed as mean SEM *p<0.001 
 
TBARS – Thiobarbituric acid 
IU IU 
Control 126.08 ± 0.76 106.266 ± 0.77 
Doxorubicin 292.03 ± 0.77 216.53 ± 0.68 
EXS(100)  203.03 ± 0.8* 176.65 ± 0.85* 
 EXS(200) 134.98 ± 1.04* 133.15 ± 0.79* 
EAXS(10) 130.01 ± 0.6* 124.81 ± 1.10* 
Groups 
TBARS 
nmoles/g 
protein 
GSH  
nmoles/g 
protein 
Control 60.15 ± 0.67 2.86 ± 0.3 
Doxorubicin 129.11± 0.76  5.01 ± 0.2 
EXS(100)  104.96 ± 1.1* 2.68 ± 0.2* 
 EXS(200) 81.98 ± 0.91* 2.38 ± 0.1* 
EAXS(10) 75.55 ± 0.9* 2.06 ± 0.2* 
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GSH    - Reduced glutathione  
 
HISTOPATHOLOGICAL STUDIES: 
The hearts isolated from each group were preserved in 10% formalin, 
processed and embedded in paraffin blocks.  A four µm thick paraffin section were 
cut and stained with eosin and hematoxyin over a glass slide.  They were observed 
under light microscope and the pathological changes were recorded. 
 
STATISTICAL ANALYSIS: 
All the datas were expressed as standard error of mean (SEM).  Data of biochemical 
parameters were analysed using one way ANOVA. Tukeys’s multiple range test was 
applied for post-hoc analysis. A value of p <0.001 was considered to be statistically 
significant. 
 
 
 
 
 
 
 
 
 
 
 
PART III 
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INVITRO ANTIARTHRITIC ACTIVITY 
86-91 
Rheumatoid arthritis is an autoimmune disorder.  One among the cause for the 
disease is due to the denaturation of the protein. Antiarthritic activity was studied by 
inhibition of protein denaturation method . 
MATERIALS REQUIRED 
Test Extracts              EXS(Ethanolic extract of X.Strumarium) and        
EAXS(ethylacetate fraction of X.strumarium) 
Standard Drug             Diclofenac sodium(250 µg/ml) 
Chemicals And Solutions   Bovine serum albumin (5% w/v aqueous  
solution) 
                Phosbphate buffer (P
H 
 6.3) 
Instrument                                          UV/ Visible  spectrophotometer at 416 nm. 
 
EXPERIMENTAL PROTOCOL 
The following four solutions were prepared 
1. Test solution (0.5ml) 
The test solution consists of 0.45ml bovine serum albumin (5% w/v 
aqueous solution) and 0.05ml of test solution (100, 200, 400, 800, 1000 µg/ml 
concentrations of EXS (or) 50, 100, 150, 200, 250 µg/ml concentrations of 
EAXS ) 
2. Test control solution (0.05ml) 
The test control solution consists of 0.45ml bovine serum albumin and 
0.05ml distilled water.   
 
3. Product control (0.5ml) 
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The product control consists of 0.45ml distilled water and 0.05ml test 
solution (of different concentrations). 
4. Standard solution (0.5ml)  
Standard solution consists of 0.45ml of bovine serum albumin and 
0.05ml of Diclofenac sodium solution (250µg/ml). 
All the above test samples was adjusted to p
H 
 6.3 using a small amount 
of 1N HCL.  They were incubated at 37
0
C for 20 minutes and heated at 57
0  
C 
for 3 minutes.  Allow to cool and about 2.5ml of phosphate buffer (p
H 
 6.3) 
was added to all the above solution. The absorbance was measured using UV 
spectrophotometer at 416nm.  The percentage inhibition of protein 
denaturation was calculated using the formula. 
 
Percentage inhibition = 100 -  { (OD of test solution-OD of product control)} 
      OD of test control 
                     
The control represents 100% protein denaturation.  The results were compared 
with the standard drug, diclofenac sodium (250µg/ml) treated sample. The results 
were presented in table 17, fig 20. 
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Table 17      Effect of EXS and EAXS on Inhibition of Protein Denaturaion 
 
 
 
 
 
 
 
                                                
*mean of three readings ± SEM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.NO 
                               % inhibition 
Conc. in 
µg/ml 
       
       EXS 
Conc.  in  
µg/ml 
    
    EAXS 
1 100 55.62 ± 2.65 50 64.76 ± 2.68  
2 200 62.28 ± 3.74 100 68.21 ± 1.39 
3 400 76.59 ± 1.45 150 73.53 ± 4.15 
4 800 81.77 ±2.89 200 77.92 ± 2.57 
5 1000 85.98 ± 4.37 250 82.56 ± 5.90 
Pharmacological Screening 
 
Department of Pharmacognosy, MMC  83 
 
PART IV 
ANTIBACTERIAL ACTIVITY AGAINST RHEUMATIC FEVER AND 
ENDOCARDITIS
92,93,94 
Ethanolic extract of xanthium strumarium and its ethylacetate fraction of 
xanthium strumarium were screened for the antibacterial effect against the 
microorganisms causing rheumatic fever and endocarditis. 
MATERIALS REQUIRED 
Medium  
Blood agar medium was used for Streptococi pyrogenes and Muller Hinton 
Agar (MH, Hi media) was used for Streptococci viridians and  Enterococci faecalis.  
Microrganisms 
 Streptococi pyrogenes 
 Streptococci viridians  
 Enterococci faecalis 
Drugs  
Ethanolic extract of X.S (EXS) and Ethyl acetate fraction of X.S 
(EAXS).Penicilin was used as the standard drug.(dose) 
EXPERIMENTAL PROCEDURE 
Disc Diffusion technique  
The pathogenic strains were then seeded on the blood agar and MH media in a 
petridish by streaking the plate with the help of a sterile swab. Care was taken for the 
even distribution of culture all over the plate. The seeded plates were allowed to dry 
Test Procedure 
The plain sterile discs of 6mm diameter were obtained from Hi Media. The 
discs were then impregnated with different concentrations of the EXS and EAXS in 
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solvent DMSO. Penicillin disc was used as the standard. Each disc contained 30g. 
The penicillin and extract discs were then placed on the seeded medium plates. The 
plates were then incubated at 37
o
C for 24h. The results were read by the presence or 
absence of zone of inhibition. The zone of inhibition was measured. The results were 
tabulated in table 18s 
Table 18  Anti – bacterial activity of EXS and EAXS 
 
 
 
S.no 
 
 
 
Organism 
 
STD 
 
EXS 
 
EAXS 
Conc in 
µg 
Zone of 
inhibition  
(mm) 
 
Conc in 
mg 
Zone of 
inhibition 
(mm) 
 
Conc in 
mcg 
Zone of 
inhibition 
(mm) 
1 Streptococcus 
pyrogenes 
 
 
 
 
30 
22 2 
4 
6 
2 
8 
12 
100 
200 
300 
8 
14 
20 
2 Streptococcus 
viridians 
25 2 
4 
6 
- 
4 
12 
100 
200 
300 
10 
16 
22 
3 Enterococcus 
faecalis 
26 2 
4 
6 
- 
4 
12 
100 
200 
300 
8 
15 
22 
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CHAPTER 7 
RESULT AND DISCUSSION 
 
Xanthium strumarium linn (Asteracea) commonly known as cocklebur is a weed 
distributed throughout India. Various phytoconstituents has been reported in this plant 
such as flavanoids, tannins, phenols. This plant has been reported to possess diuretic, 
antidiabetic, antimalarial, cytotoxic, antibacterial and antifungal activities. This 
dissertation work includes the pharmacognostical ,phytochemical and pharmacological 
studies on the leaves of Xanthium strumarium. 
Chapter 1 
 Introduction of this dissertation work has been discussed in this chapter which 
gives information about herbal plants, its safety, pharmacovigilance, quality control and 
scientific validation. A brief note on antioxidants, heart failure, its etiology, clinical 
management, cardiomyopathy, cardiotoxicity, cardiotoxic agents, herbal remedies used as 
cardioprotective  agent were discussed in this chapter. Rheumatoid arthiritis, its sign and 
symptoms, diagnosis, treatment, herbal drugs used in the treatment of this disease. 
Rheumatic fever, its cause, mechanism and the treatment have  also been discussed in this 
chapter. 
Chapter 2 
Literature survey pertaining to the pharmacognostical, phytochemical,  
pharmacological studies of Xanthium strumarium were discussed in this chapter. The 
Ethnomedical information revealed that the plant is used for the treatment of rheumatoid 
Result And Discussion 
 
Department of Pharmacognosy, MMC.  86 
 
arthritis, cardiac problems, kidney diseases, malaria, diabetes, tumour and also possess 
antibacterial and antifungal activity. 
Chapter 3 
Aim and scope of the present work has been discussed in this chapter considering 
the ethnomedical information and chemical nature of phytoconstituents present in this 
plant. 
Chapter 4 
This chapter deals with the pharmacognostical studies on the leaves of this plant. 
The systematic position, habit & habitat and description of the plant were discussed in 
this chapter. An attempt has also been made to standardize the leaves of this plant by 
means of organoleptic, microscopical and physical evaluation and the results were 
tabulated.  
Macroscopical studies 
 The leaves are cordate or sub – orbicular in shape, irregular toothed margin and 
cuneate apex. 
Microscopical studies 
The following anatomical characters were found in the T.S of the leaves. The leaf 
consists of very thick midrib and thin lamina. Actinocytic stomata are present on both 
adaxial and abaxial part of the epidermis.  Both glandular and non glandular trichomes 
are present on the sides of the lamina and the glandular trichomes are not much 
prominent. Non glandular trichomes are 2-5 celled uniseriate, unbranched and thin 
walled. Glandular trichomes are small, delicate, dumbbell shaped and two celled. They 
are situated in the shallow pits of the epidermis. Parenchymatous ground tissue also 
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consists of circular secretory cannals with a ring of epithelial cells. Vascular system of 
the midrib is multistranded. About five bundles are arranged in a shallow arc along the 
abaxial part and two bundles are located in the adaxial part.  
Petiole consists of  basal , middle and terminal part. It consists of three epidermal 
layers followed by four or five layers of collenchymas cells and rest of the ground tissue 
consists of large thin walled parenchyma cells. Secretory canals with epithelial cells are 
scattered in the ground tissue. Vascular system exhibits much variation in the three 
regions of the petiole. 
Powder microscopy 
The powder microscopy of the leaves showed the following distinct features. 
 Epidermis with actinocytic stomata. 
 Multicellular, uniseriate and unbranched non glandular trichlomes. 
 Delicate dumbbell shaped, two celled glandular trichlomes are rarely seen. 
 Secretory cells surrounded by epithelial cells along with parenchyma cells. 
 Liginfied, spiral xylem vessels. 
Quantitative microscopy 
 Leaf constants such as stomatal number, stomatal index, vein islet, vein 
termination were determined for the leaves of this plant and the results were tabulated 
(table 1) 
The physical parameters like ash value (total ash, water soluble ash, acid insoluble 
ash), loss on drying and extractive value were determined for various solvents and the 
results were presented in the table  (table 2 and 3 ) 
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      Ethanolic extract (75%) showed highest extractive value (6.44 %). When 
compared to ethanolic extract(95%) (2.33%), chloroform extract (4.01%), petroleum 
ether extract (0.47%) and the results were presented in table. 
Table 1: Quantitative microscopical 
parameters of the leaf of Xanthium strumarium. 
S. No. 
 
Parameters* *Values obtained 
1 Stomatal number  in upper epidermis 103.26  ± 0.12 
2. Stomatal number  in lower epidermis 227.43 ± 0.32 
3. Stomatal index in upper epidermis  17.63 ± 0.34 
4. Stomatal index in lower epidermis  26.54 ± 0.63 
5. Vein islet number 13.49 ± 0.13 
6 Vein termination number 2.63 ± 0.24 
     * mean of three readings 
Table 2: Analytical parameters of X.strumarium 
S. No Parameters* Values* expressed as % 
1 Ash values   
 Total ash  11.42  ± 1.34 
 Water insoluble 6.57 ± 0.95 
 Water  soluble ash 4.85 ± 0.74 
 Acid  insoluble ash  2.49 ± 0.62 
2 Loss on drying 2.14 ± 0.31 
* mean of three readings 
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Table 3: Extractive values of X.strumarium 
S. No Parameters* Values* expressed 
as % 
 Extractive  values   
     1 Petroleum ether extract 0.4765 
2 Ether extract 3.517 
3 Hexane 3.318 
4 Chloroform 4.015 
5 Acetone 1.559 
6 Methanol 3.289 
7 Ethanol 2.335 
8 75% Ethanol 6.437 
9 Aqueous 5.218 
 
Chapter-4 
             Collection, authentication and preparation of plant extract have been discussed in 
this chapter. Both powdered leaf material and various extracts were subjected to 
preliminary phytochemical studies which indicates the presence of flavanoids, tannin, 
phenols, alkaloids and saponins. The phytochemical study also revealed that ethanolic 
extract(95%) showed the presence of almost all the phytoconstituents viz. Flavanoids, 
tannin, phenols, and alkaloids and these phytoconstituents also reported to possess 
significant therapeutic potential for the treatment of various diseases. Hence ethanolic 
extract(75%) showed highest extractive value (6.44%) and therapeutically viable 
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phytoconstituents are also present. So it has been choosen for the phytochemical and 
pharmacological studies 
This part of the study deals with extraction of plant materials with ethanol(75%) 
by triple maceration. Preparation of phenolic rich extract form ethanolic extract of X.S by 
fractionation using hexane, chloroform, ethylacetate and n-butanol were discussed in this 
chapter. 
Ethylacetate fraction showed highest phenolic content (278.6mg/kg ) compared to 
hexane( 181.96mg/kg ), chloroform(168.76mg/kg), n-butanol (149.66mg/kg) fractions. 
This study revealed that the total phenolic content was found to be 221.96mg/kg and 
278.66mg/kg for  EXS and EAXS respectively 
This study indicate that the ethylacetate rich fraction exhibited highest phenolic 
content when compared to other fractions and also revealed that both EXS and EAXS 
showed significant concentration of phenolic compounds. 
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            Total phenol, total tannin and total favanoid content 
Extracts  Total phenol 
content mg/g 
Total tannin 
content mg/g 
Total flavanoid 
content mg/g 
EXS 221.9 ± 0.76 
 
327 ± 0.72 
 
23.03 ± 0.2 
Phenolic rich 
extract 
   
Hexane 181.9 ± 0.6 
 
- - 
Chloroform 168.7 ± 0.50 
 
- - 
Ethylacetate 278.6  ± 0.49 
 
- - 
n-butanol 149.6 ± 0.73 - - 
* mean of three readings 
TLC and HPTLC studies   
This chapter deals with the TLC and HPTLC studies on EXS and EAXS. EXS 
and all the phenolic fractions were subjected to TLC studies which revealed that EXS, 
ethylacetate, chloroform and hexane fraction showed three spots each and n-butanol 
fraction exhibited only one spot 
HPTLC chromatogram was recorded for both EXS and EAXS. HPTLC 
chromatogram of EXS indicate that about eleven peaks were obtained at 254nm and nine 
peaks were obtained at 366nm. HPTLC chromatogram of EAXS showed that about ten 
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peaks were obtained at 254nm and three peaks were obtained in 366nm. This HPTLC 
study also showed that about eleven phytoconstituents were present in EXS and ten 
phytoconstituents were present in EAXS.  
Table 12: Phytochemical evaluation of ethanolic exract and phenolic rich 
fractions by TLC studies. 
S.NO SOLVENT 
SYSTEM 
EXTRACT NO. OF 
SPOTS 
RF 
VALUE 
DETECTING 
AGENT 
 1.  
 
 
 
 
 
 
TOLUENE : 
ETHYLACETATE: 
FORMIC ACID 
7 : 3 : 0.2 
 
EXS 
 
  3 
0.7 
0.8 
0.9 
 
 
 
 
 
 
 
UV -  365 
 Phenolic rich 
fraction 
 
2  
Hexane 
 
3 
0.71 
0.81 
0.89 
3  
Chloroform 
 
3 
O.4 
0.52 
0.75 
4  
Ethylacetate 
 
3 
0.39 
0.63 
0.72 
5  
N-butanol 
 
1 
 
0.56 
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Chapter 5 
 This chapter deals with the pharmacological screening of both EXS and EAXS for 
invitro antioxidant,  cardioprotective, anti- arthritic and anti-bacterial activity. 
Part I  
 Radical scavenging activity was determined for EXS and EAXS by DPPH assay.  
The percentage inhibition of EXS (100µg/ml) and EAXS (25µg/ml) were found to be 
78% and 85% respectively when compared to the standard ascorbic acid 93.73% 
(100µg/m).  IC50 of EXS and EAXS were found to be 52.65µg/ml and 11.25µg/ml 
respectively when compared to the standard ascorbic acid (47.04µg/ml).  This study 
showed that both EXS and EAXS exhibited significant radical scavenging activity but 
EXS has also shown more potent activity than ascorbic acid. 
 Nitric oxide scavenging was determined for EXS. At 222µg/ml percentage 
inhibition of EXS and ascorbic acid were found to be 72.12% and 80.03% respectively.  
EXS and ascorbic acid showed the IC50 value of 113.48µg/ml and 84.64µg/ml 
respectively.  This study revealed that EXS showed significant nitric oxide scavenging 
inhibition assay when compared to ascorbic acid. 
 EXS was also determined for the total antioxidant potential by 
phosphomolybdenum method.  Total antioxidant potential of EXS was found to be 1.906 
(200 µg/ml) when compared to ascorbic acid 3.515 (15 µg/ml).  This study revealed that 
EXS exhibited significant total antioxidant potential when compared to ascorbic acid. 
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Part II 
 This part of pharmacological study is concerned with the evaluation of cardio 
protective effect of EXS and EAXS on Doxorubicin induced cardiotoxicity in rats. This 
study involves the estimation of biochemical parameters in the serum such CK-MB, LDH 
and TBARS, GSH in the heart tissue homogenate of the rat. 
 Doxorubicin treated animals, the serum LDH (p<0.001) and CK-MB (p<0.001) 
were increased significantly when compared to the serum parameters of the control 
animals. It was also found that, there was significant increase in TBARS level (p<0.001) 
and significant decrease in GSH level (p<0.001) as compared to the tissue parameters of 
the control animals. 
 At 100mg/kg EXS treatment, the serum LDH (p<0.001) and CK-MB (p<0.001) 
were found to be decreased when compared to the serum parameters of the Doxorubicin 
treated animals. The TBARS level (p <0.001) was decreased and GSH level (p<0.001) 
was elevated compared to the tissue parameters of the doxorubicin treated animals. 
 At 200mg/kg EXS treatment, the serum LDH (p<0.001) and CK-MB (p<0.001) 
level were significantly decreased as compared to the serum parameters of the 
Doxorubicin treated animals. The TBARS level (p< 0.001) was significantly decreased 
and GSH level (p<0.001) was significantly increased as compared to the tissue 
parameters of the doxorubicin treated animals. 
At 10mg/kg EAXS, the serum LDH (p<0.001) and CK-MB (p<0.001) level were  
decreased significantly  when compared to the serum parameters of the Doxorubicin 
treated animals. The TBARS level (p<0.001) was decreased significantly and GSH level 
Result And Discussion 
 
Department of Pharmacognosy, MMC.  95 
 
(p<0.001) was increased significantly when compared to the tissue parameters of the 
doxorubicin treated animals 
Histopathological studies 
 In the histopathological studies, the control animals showed normal myocardial 
structure. The incidence of marked cyoplasmic vacuoles, nuclear pyknosis and dilated 
blood vessels were observed in Doxorubicin treated animals. Treatment with 100 mg/kg 
EXS, 200mg/kg EXS and 10 mg/kg EAXS showed no significant pathological changes 
and the extract possess cardioprotecive activity against Doxorubicin. 
 
 Fig 18  Effect of EXS and EAXS on serum biochemical parameters 
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Fig19  Effect of  EXS and EAXS on tisssue biochemical parameters 
 
Discussion 
 Doxorubicin, a powerful antineoplastic agent causes systolic dysfunction and 
ventricular arrhythmia in a dose dependent manner (>450mg/m² and frequent with 
>550mg/m²). By measuring the cardiac specific troponin and monitoring by 
echocardiography, it was found that Doxorubincin administration deteriorated LV 
function of the heart. 
The development of these complications appears to be related to the oxidative stress, free 
radical generation, damage of inner mitochondrial membrane and interference with the 
synthesis of adenosine triphosphate  (ATP) 
 Doxorubicin possess quinone and hydroquinone moieties. Doxorubicin  
undergoes one electron reduction to form intermediate semiquinone  radical  which in 
turn reacts with oxygen to form superoxide anion radicals. This superoxide anion radical 
is capable of generating both hydrogen peroxide and hydroxyl radical which attacks DNA  
and oxidizes DNA bases.   
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 Oxygen radical induced injury in the lipid membrane was considered to be 
responsible for Doxorubicin induced cardiotoxiciry. Oxidative stress, lipid peroxidation 
and generation of free radical induced by doxorubicin leads to increased CK-MB, LDH, 
TBARS level and decreased GSH level. EXS and EAXS treated animals resulted 
elevation  of endogenous GSH and reduction of CK-MB, LDH and TBARS. 
 The leaf has been reported for the presence of tannins. It is evident that 
polyphenolic  compounds (flavanoids, tannins) were present in both EXS and EAXS. 
Both EXS(221.9mg/g) and EAXS( 278.6mg/g) were estimated for the total phenolic 
content which revealed that these extracts consists of phenolic compounds significantly. 
Preliminary phytochemical studies indicate presence the phenolic constituents 
such as flavanoids, tannins in EXS. Quantification of EXS for total flavanoids, total 
phenol and total tannin content showed the highest concentration of phenolic 
constituents.  
Both EXS and EAXS showed potential invitro antioxidant activity by DPPH 
assay, Nitric oxide scavenging activity and phosphomolybdenum method. Mechanism 
behind the cardiotoxicity is free radical generation and oxidative stress. These plant 
extract also exhibited invivo antioxidant activity by elevating endogenous antioxidant 
GSH and suppressing the formation of  TBARS in cardiac tissue. 
The presence of antioxidant potential and polyphenolic conpounds in EXS and 
EAXS may be responsible for the significant decrease in the LDH,CKMB,TBARS and 
significant increase in GSH levels. Hence the result suggested that the cardioprotective 
effect against doxorubicin induced cardiotoxicty at 100mg/kg  & 200mg/kg of EXS and 
10mg/kg of EAXS. 
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PART  II 
This part of the pharmacological study deals with the in vitro antiarthritic activity of both 
EXS and EAXS 
The principle involved is the inhibition of protein denaturation. Denaturation of 
protein was found to be one of the cause of rheumatoid arthritis. In rheumatoid arthritis 
the autoantigen production may be due to denaturation of protein. The mechanism of 
denaturation involves the alteration of electrostatic hydrogen, hydrophopic and disulphide 
bonding. 
           The protein used in this study is bovine serum albumin. Denaturation of protein is 
carried out   by heating. The phenomenon of denaturation of protein by heat was 
determined by Mizushima, 1996.  The aim of this activity is to inhibit denaturation and to 
exhibit protective effect against rheumatoid arthritis. Various concentrations of EXS 
(100, 200, 400, 800, 1000 µg/ml) and EAXS (50,100,150,200,250 µg/ml) were subjected 
to invitro antiarthritic activity. The percentage inhibition of protein denaturation by EXS 
and EAXS were  compared with standard drug (Diclofenac sodium 250 µg/ml). The 
results were presented in the table.  
It has been reported that anti athritic activity may be due to the presence of phenolic 
compounds .The inhibition of protein denaturation by EXS and EAXS were may be due 
to the presence of flavanoids, tannins. The EXS showed 85.98  % inhibition at 1000 
µg/ml and EAXS showed   82.56%  inhibition at 250µg/ml when compared to standard 
drug Diclofenac sodium 92%(250µg/ml) 
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Fig 20   Effect of EXS and EAXS on Inhibition of Protein Denaturaion 
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PART III 
INVITRO ANTI-BACTERIAL ACTIVITY 
This part of the pharmacological study deals with the anti-bacterial activity against 
causative organisms for rheumatic fever and endocarditis. 
Both EXS and EAXS were subjected to anti-bacterial activity against 
Streptococcus pyrogenes, Streptococcus viridians and Enterococcus faecalis.  
Zone of inhibition of EXS (6mg) was found to be, Streptococcus 
pyrogenes,(12mm) Streptococcus viridians(12mm) and Enterococcus faecalis(12mm) 
compared to penicillin. Zone of inhibition of EAXS was found to be, Enterococcus 
faecalis(22mm) Streptococcus pyrogenes,(20mm) and Streptococcus viridians(22mm), 
which indicate that this fraction has exerted significant anti-bacterial activity against all 
the three bacterial pathogens than EXS when compared to the standard drug penicillin. 
 
 
 
 
 
FIG : 1.1  T.S OF LEAF THROUGH MIDRIB 
 
 
FIG : 1.2   T.S OF MIDRID ENLARGED 
 
 
FIG : 2.1   T.S OF LAMINA SHOWING EPIDERMAL 
TRICHOMES AND MESOPHYLL TISSUE 
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FIG : 4.1   PARADERMAL SECTION OF THE LAMINA 
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FIG : 4.2   PARADERMAL SECTION OF THE LAMINA 
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FIG : 5.1 SURFACE VIEW OF STOMATA 
 
 
FIG : 5.2 PARADERMAL SECTION SHOWING 
VENATION OF THE LAMINA 
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FIG : 6.2 GLANDULAR TRICHOMES ENLARGED 
 
 
FIG : 7.1,2  T.S OF BASAL PART OF PETIOLE 
 
 
 
 
 
 
 
 
FIG : 8.1  T.S OF MIDDLE PART OF PETIOLE 
 
 
 
FIG : 8.2  ONE SECTOR ENLARGE 
 
 
 
FIG : 9.1 T.S. OF TERMINAL PART OF PETIOLE 
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FIG : 10.1  FRAGMENTS OF THE LEAF IN THE 
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FIG : 10.3  EPIDERMAL NON GLANDULAR 
TRICHOMES 
 
 
 
Fig: 12 FLOWER OF XANTHIUM STRUMARIUM 
 
 
 
 Fig 13 FRUITS OF XANTHIUM STRUMARIUM 
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Fig 14 LEAVES OF XANTHIUM STRUMARIUM 
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CHAPTER-8 
CONCLUSION 
  There are many unknown plants with high medicinal value still have not been 
recognised their importance. They have not been brought to the light of scientific 
world. This dissertation covers pharmacognostical, phytochemical and 
pharmacological studies on the commonly available medicinal plant Xanthium 
strumarium belonging to the family asteracea. 
  Pharmacognostical parameters have been determined on the leaves inorder to 
substantiate and identify the plant for future work. 
  Preliminary phytochemical screening on the leaves of X.strumarium confirms 
the presence of flavanoids, phenols, tannins, sterols, alkaloids, carbohydrates and 
saponins. 
  Preparation of extract and isolation of phenolic rich fractions were carried out 
in this study. 
  Determination of total phenolics(221.9mg/g), total tannins(327mg/g ) and total 
flavanoid content(23.03mg/g) confirms the significant concentration of these 
phytoconstituents in the ethanolic extract of X.strumarium. Total phenolic content was 
estimated for all the phenolic rich fractions which indicate that ethylacetate fraction 
have shown significant phenolic content.. Evaluation of phytoconstituents were 
performed by TLC and HPTLC studies on EXS and EAXS 
  Pharmacological screening confirms, 
  Both EXS and EAXS have exhibited radical scavenging activity by DPPH 
assay and EXS has shown radical scavenging activity by nitric oxide 
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scavenging and it also exerted significant antioxidant potential by  
phosphomolybdenum method. 
 Significant cardioprotective activity at 100mg/kg of EXS (p<0.001), 200 
mg/kg of EXS (p<0.001)and 10 mg/kg EAXS(p<0.001) against Doxorubicin 
induced cardiotoxicity in rats and the invivo antioxidant activity of these 
extracts may be ascribed for this cardioprotective activity which is confirmed 
by elevation of GSH (p<0.001)and reduction of TBARS (p<0.001) in the 
tissue parameters of the treated animals. 
 1000μg/ml of EXS and 250 μg/ml of EAXS showed significant anti – arthritic 
activity by inhibition  of protein denaturation. 
 Significant anti-bacterial activity exhibited by EAXS (300mcg) against 
Streptococcus pyrogenes which is a causative organism for rheumatic fever. 
Streptococci viridians and Enterococci faecalis also sensitive to this extracts 
and these pathogens cause endocarditis. Anti-bacterial activity of this extract 
was comparable with standard drug penicillin. 
  It was evident from the phytochemical studies of this plant, that 
substantial amount of phenols, tannins and flavanoids were present in these 
extracts which  exhibited significant invitro antioxidant activity. 
 
 Heart failure is a burgeoning problem world wide, with more than 20 
million people were affected. The overall prevalence of HF in adult population 
is 2% and the risk rises with age affecting 6 – 10 % of people over 65 years of 
age. Cardiomyopathy may be due to viruses, amyloidosis, diabetes, thyroid 
diseases, medications such as chemotheraphy drugs (Doxorubicin, 
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Donorubicin,etc). Though many synthetic cardioprotective agents are 
available, herbal drugs are preferred for their safety and efficacy. 
 
 Cardiotoxicity was induced in the animal model using Doxorubicin 
(antineoplastic agent). Doxorubicin cause oxidative stress leads to cardiac 
tissue damage at 15mg/kg i.p in rats. Cardioprotective activity of these 
extracts may be due to the presence of phenolic phytoconstituents by virtue of 
their antioxidant and radical scavenging properties. 
  
 Rheumatiod arthiritis being a common inflammatory disease affects 
about 1% of the adult population worldwide. It occurs in an 
immunogenitically predisposed individuals. Protein denaturation was found to 
be one of the cause of R.A. Both EXS and EAXS have shown significant anti- 
arthritic activity and the phenolic constituents may be responsible for this 
activity.  
  
     These extracts have also shown significant anti-bacterial activity against 
the pathogens caused for rheumatic fever and endocarditis. Phenolic 
phytoconstituents may be responsible for this activity. 
 
 Phenolic secondary metabolite responsible for invitro antioxidant, 
cardioprotective activity, anti-arthritic activity and anti bacterial activity may 
be isolated and evaluated for further studies. 
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 It may also surve as a lead molecule to synthesise various 
semisynthetic drugs to treat various life threatening diseases like CHF, RA, 
rheumatic fever caused by Streptococcus pyrogenes and endocarditis caused 
by Enterococcus faecalis, Streptococci viridians. 
